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The first part of this thesis examines Ofloxacin (Oflo), a second-generation quinolone, by
applying 1D 1H NMR. Molecular dynamics, stacking conditions and the self-diffusion constant
were investigated.
No certain conclusion could be drawn concerning molecular dynamics. It appears like hindering
of the ring-rotation initiated by hydrogen bonding arising from the F9 and O1 is the reason for
the coalescence observed in the 1H NMR spectrum. Slow inversion of the methylpiperazine
ring cannot be excluded.
It was confirmed that no stacking occurs in the concentration range 1 - 6 mM and the self-dif-
fusion constant was determined to be 4.33 (± 0.07) * 10-10 m2s-1. The self-diffusion constant
appears to depend on concentration, but the dependency was within the limits of error in the
concentration range used in this thesis, and it has therefore been regarded as independent of
concentration.
In the second part of this thesis the 1D 1H and 2D NOESY NMR spectra of a palindromic
decamer T1A2T3G4G5C6C7A8T9A10 (named GGCC) were investigated and the self-diffusion con-
stant calculated to be 1.33 (±0.07) * 10-10m2s-1.
The third part of this thesis combines GGCC and Oflo in a series of titrations. 1D 1H NMR
spectra and diffusion constants were obtained at 11 different Oflo:GGCC ration. A NOESY
spectrum was obtained for the last titration.
A model for the interaction between Ofloxacin and GGCC has been proposed. This model
postulates both minor/major groove and intercalation interactions. The minor/major groove
interaction occurs at all concentration levels, the intercalation is initiated at a Oflo:GGCC ratio
of 1. The minor/major groove interaction and the intercalation appear to be linked.
The results fail to exclude other models of interaction. The only certain conclusion may there-
fore be that intercalation takes place, but there appears to be more than one interaction mode.
Summary
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The first quinolone, Nalidixic acid (Nal), was synthesized in 1962 by Lesher et al. Since then
quinolones have developed and are today regarded as an important group of antimicrobial agents.
Ofloxacin (Oflo) is a second-generation fluoroquinolone and has been in clinical use for more
than a decade. Oflo is a racemic mixture as it containes a chiral centre (marked by * in figure 1.1).
The pure (-)S isomer of Oflo is the most active enantiomer and in its pure form considered a third
generation quinolone called Levofloxacin (Levo). Oflo is highly active against Gram-negative
bacilli, less active against Gram-positive coccus and is not sufficiently active against anaerobic bac-
teria for medicinal purposes. For therapeutic purposes it is used in complicated urinary tract and
catheter-related infections, prostatitis and some sexually transmitted diseases among others.
Oflo, along with Ciprofloxacin (Cipro), are the most widely used second-generation quinolones.
Oflo has been the centre of great interest both as a drug and as model system for quinolone inve-
stigations. 3.361 articles regarding Ofloxacin and 1.219 regarding Levofloxacin were found when
searching the ISI Web of KNOWLEDGE indicating the immense interest in these compounds.
In Gram negative bacteria Oflo is active against the DNA gyrase enzyme that super coils DNA
and removes knots by cleavage of the helix. The enzyme is essential for all bacteria and blocking
the enzyme will eventually lead to cell death. In Gram-positive bacteria, however, the target for
blocking is the topoisomerase IV enzyme. More information on quinolones and mechanisms of
reaction is given in the theory, chapter 3.
Quinolones are the first man-made antimicrobials. Knowledge of how quinolones function will
be important in the search for new antimicrobials. Resistancy against antimicrobial agents are of
great concern and multidrug resistant bacteria may cause severe problems in the future. Leading
1. Introduction
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Figure 0.1 Nalidixic acid a) and Ofloxacin b)
a) b)
Introduction
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experts are concerned with the coming of a post-antibiotic area. This is the reason why it is
immensely vital to investigate the molecular mechanisms of action for antimicrobials and find the
pathways leading to antimicrobial resistance.
The aim of this project is to gain insight on how quinolones interact with DNA and to find the
properties making Oflo one of the most efficient second-generation quinolones.
A model system of the interaction between a quinolone and DNA is employed consisting of Oflo
and a model DNA oligomer. The self-complementary decamer oligonucleotide d(TATGGCCA-
TA)*d(ATACCGGTAT) was used as a model for DNA. The oligomer will from hereon be refer-
red to as GGCC.
Different mechanisms on how quinolones interact with DNA have been proposed. Several struc-
tures and theories on where the quionolone are most likely to interact with DNA have also been
reported.
The project consists of three different parts where the following problems are investigated:
The first part concerns different properties of Oflo. The methylpiperazine ring, which is consi-
dered important to cell-penetration, has a hindered motion. Termodynamic parameters for this
motion has been calculated using NMR techniques.
Some theories postulate stacking of the quinolones before interacting with the DNA or while
interacting in DNA. Stacking conditions of Oflo at several concentrations were investigated using
NMR diffusion measurements to monitor changes in the stacking conditions. This constitutes the
second part of this thesis.
The third part investigates the interaction between the quinolone and DNA. Self-diffusion con-
stants of Oflo and GGCC were measured separately and in a mixture of Oflo and GGCC apply-
ing NMR diffusion measurements techniques. The association constant of the Oflo-GGCC inter-
action was calculated using different techniques.
2. Deoxyribonucleic acid
Deoxyribonucleic acid (DNA) was first discovered by Friedrich Meischer in 1868. As research
proceeded DNA´s role in replication was discovered, but not until 1943. Solving the secondary
structure of this macromolecule still proved difficult, and finally James D. Watson and Francis
Crick suggested the double helix in 1953. For their work Watson and Crick was awarded the Nobel
Prize in Chemistry together with Maurice Wilkins. Some say that the basis for Watson and Crick´s
discovery was the ground-breaking x-ray diffraction work performed by Rosalind Franklin who
worked at the same laboratory.
As the secondary structure was solved, the functional properties of DNA could finally be investi-
gated. The current knowledge on DNA and how it functions is extensive. It is even a househeld
term used in daily conversations and the media around the world. However there are still new
applications for DNA to be discovered. The latest application of DNA (or other similar oligo-
mers) is in the field of nanotechnology, giving rise to even smaller microprocessors and other
miniature equipment.
2.1 DNA structure[1]
The primary structure of DNA is relatively simple. It is built up from only four different nucleic
bases, a deoxyribose sugar ring and a phosphate group. The nucleic bases are: Guanine (G),
Adenine (A), Cytosine (C) and Thymine (T).
The bases are attached to the sugar ring and the sugar rings and phosphate group constitute the
backbone in a strand of bases.
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a) b)
c) d)
e)
Figure 2.1 The nucleic bases a) Adenine, b) Guanine, c) Cytocine, d) Thymine and e) the sugar ring with a phos-
phate groupe attached in 5’ position. 
Theory - Part A:
Each sugar ring has two phosphate groups attached, one in the 5´ position and the other in
the 3´ position:
The order of the bases is important, hence we need to define the direction of the strand. By con-
vention the strand is always read from the 5´ side to the 3´ side. However simple in its con-
struction, the DNA single strand is remarkably flexible. The bonds between the sugar ring and the
base and between the sugar ring and both the phosphates can rotate 360° though there are some
retrictions in the helix conformation. The sugar ring is not perfectly planar, giving rise to 20 dis-
tinct conformations as a result of puckering.
Two DNA strands are needed to constitute a DNA helix. The base pairs in each strand are con-
nected by hydrogen bonds to each other. If the sequence of one strand is known, the other is
given since there are only two base pairs: GC and AT. The strands are complementary and anti-
parallel.
The GC base pair is stronger than the AT base pair since there are three H-bonds between G and
Theory - Part A: Deoxyribonucleic acid
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Figure 2.2 Possible configurations of the sugar ring due to puckering. The 2 and 3 carbon positions are used to
define the conformation. The C3´-endo and C2´-endo are preferred conformations[1]p44.
C and only two between A and T. This is especially important in small DNA fragments as AT base
pairing at the end of the fragment results in less stable helixes.
In a double helix, the rotation around the bonds between the sugar ring and the base, and between
the sugar ring and the phosphates are somewhat restrained. Still the molecule is remarkably
flexible. This means that the helix can be twisted either to the right (right-handed DNA) or to the
left (left-handed DNA) and that the base pairs could be twisted, rolled or tilted.
14
Figure 2.4 a) Illustration of the double helix construction and definition of angles in a helix conformation and b)
definitions of twisting, rolling and tilting of the DNA bases[1]p51.
Theory - Part A: Deoxyribonucleic acid
a) b)
Figure 2.3 a) AT pairing and b) GC pairing. AT are connected by two hydrogen bonds and GT by three[1]p49.
This flexibility leads to three different double helix conformations, or rather three different fami-
lies with small variations in their geometrical parameters.
The two main DNA structures are A and B
DNA. A third, Z DNA, is less common. The
B form of the DNA double helix is known to
be the typical conformation of in vivo DNA
of eucariotes.
B DNA is a right-handed double helix with
approximately 10 base pairs per turn and a 3.4
Å axial distance between the base pairs. The A
form of the double helix is also right handed.
It has approximately 11 base pairs per turn and
a 2.6 Å axial distance between the base pairs. Z
DNA is left-handed with 12 base pairs per turn
and the phosphodiester chain has a zigzag
shape, hence the name.
The base pairing and the helix shape give an
uneven opening towards the middle of the
chain. These openings are defined as the
minor- and major groove (see figure 2.1.5).
Normally the major groove is larger than the
minor groove, though not without exeptions.
Since the bases pair, the sugar phosphate back-
bone is located outwards. This part of the
DNA is negatively charged and hydrophilic,
while the inside of the helix, the bases, are
hydrophobic. This results in a high solubility
for DNA in water.
The Watson-Crick base pairing and the ideal base pairs are basically described in the section above.
In reality things are more complicated. There are several ways for the base pairs to interact, and
there are also the possibilities of mismatching pairs and even chemical altering of the bases, al-
lowing other kinds of pairing. The oligomer GGCC  used in this thesis contains “ordinary” bases
in Watson-Crick pairing.
The organisation of DNA in vivo is rather complicated. The double helix is supercoiled around
histones, which again is coiled up in telomeres that constitutes chromosomes.
Figure 2.5 Major and Minor groove in the DNA dou-
ble helix[2].
Theory - Part A: Deoxyribonucleic acid
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Different proteins at different levels stabilize the structure.
2.2 Ligands interacting with DNA
Drugs bind to DNA through one of four possible interactions: intercalation, groove binding,
covalent attachment, cross-linking or a combination of these modalities.
Intercalation is insertion of a drug or part of a drug between two adjacent base pairs. Intercalators
often contain an aromatic ring system with the aromatic ring being flat enough to fit between the
bases. The intercalation results in an increased distance between the bases and a local unwinding
of the helix. Still, because of the flexibility, the rest of the DNA helix is practically uninfluenced
by the process. The intercalation is stabilized by stacking interactions between the aromatic rings
or substituents in the grooves or on the DNA surface. An example of intercalating drug is actino-
mycin.
Both minor and major groove bindings may also occur. The geometry of the molecule is more
important in minor groove bindings than in major groove bindings. A drug binding typically has
Theory - Part A: Deoxyribonucleic acid
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Figure 2.6 Illustration of the organisation of DNA in the cell (in vivo)[3]p58.
a structure that fits well in the minor groove. The flexibility of the helix is also playing an impor-
tant part, as the groove may adjust to fit the molecule. Once inside the minor groove the mole-
cule will be stabilized through hydrogen bonds and Van der Waals interactions. An example of
minor groove-binding drug is neutropsin.
The major groove, on the other hand, is usually bigger and the geometry of less importance. The
major groove is opening in towards the bases. This will give several possibilities for specific hydro-
gen bonds to donors and acceptors in the base pairs leading to complex stabilisation or sequence
specificity. Proteins are often bound to DNA in the major groove.
Covalently bound drugs and cross linkers interact with the bases or the phosphate backbone.
Certain drugs are base specific and bind covalently to for instance A or G sites. Cross linkers inter-
act in the same way, but utilise both of the strands in the helix, forming a bridge between the two.
An example of a bifunctional cross-linking agent is Bizelesin.
17
Theory - Part A: Deoxyribonucleic acid
The development of antimicrobial1 chemotherapeutic agents started in the 19th century with the
acceptance of the germ theory which linked micro-organisms to several diseases. To cure infecti-
ons the scientists started the hunt for “the magic bullet”.
In the late 1870s Louise Pasteur demonstrated that the bacterial disease anthrax could be cured in
animals by injecting a soil bacteria. Late 1880s Rudolf Emmerich and Oscar Low conducted expe-
riments proving that the same bacteria causing one disease could cure another, and from the bac-
teria bacillus pycyoneus they created the medicine pyocyanase to cure cholera, tyhpoid diphteria
and anthrax. This was the first antibiotic in use in hospitals. Unfortunately, the medicine had some
unexpected side-effects and after a short while the drug was no longer in use.
Alexander Fleming accidentially discovered penicillin in 1928, during an experiment that was con-
taminated by the mold bacteria Penicillium notatum. This proved to be a highly useful drug but it
was not available commercially until 1943. Fleming, Florey and Chain was awarded the Nobel
Price in medicine in 1945 for the discovery, structural assignment and synthesis of penicillin.
In 1932 another useful antimicrobial chemotherapeutic agent was discovered. Gerhard Domagk
investigated a dye called Prontsil and demonstrated that it cured streptococcus when injected in
animals. Later he discovered that the active part of Prontosil was a sulfonamide. This was the birth
of a whole range of drugs called Sulfa-drugs and by 1945 pharmacologists had 5488 different
sulfonamides. For his work with sulfonamide Domagk received the Nobel Price in medicine in
1939.
Other discoveries of importance are tetracyclines and quinolones. Tetracyclines were first found
in 1948, the first quinolone (nalixic acid) in 1962. This thesis will focus on the interaction betwe-
en DNA and the quinolone Ofloxacin (see chapter 3.3). The quinolones will be discussed further in
the following sections.
3.1 Quinolones
Quinolones are a class of antimicrobial agents developed from Nalidixic acid (Nal), discovered in
1962 by Lesher et al.[4]. They discovered Nal by chance while investigating by-products from the
synthesis of the anti-malaria drug chloroquine. Lesher proved that Nal had significant antimicro-
bial abilities as a narrow spectrum drug effective mainly on Gram negative bacteria2. With Nal a
3. The antimicrobial quinolones
1 Antimicrobials are natural, semi-natural or synthetic chemicals that can interfer directly with the growth of microbes at a very low
concentrations. Natural or semi-natural antimicrobials are often referred to as antibiotics.
2 Bacteria are mainly devided in Gram positive and Gram negative bacteria based on a colouring technique developed by Hans Christian
Gram in 1884. Gram negative bacteria have an outer membrane that the Gram positive bacteria do without.
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whole range of quinolones developed the following decade. Among the most important new
quinolones were oxolinic (oxo), cinolaxic and pipemidic.
3.2 Structure and classification
All quinolones exhibit the same ground-structure (see figure 3.1a). They all contain a carboxylic
group at the 4 position, thus the first generation quinolones are often referred to as 4-quinolo-
nes. In first generation quinolones the R1 substituent is usually an ethyl group.
In the 1980s the introduction of fluorine, mainly at the 6-position, gave rise to a second genera-
tion of quinolones, the fluoroquinolones, possessing a broad spectrum activity against microbes3.
Since the fluorine is attached to the 6-position, they are often referred to as 6-fluoroquinolones.
Second generation quinolones usually have a piperazine- or methylpiperazine ring substituated at
the R7 position and the atom at postiton 8 is usually a carbon. Otherwise they essentially contain
the same basic structure as first generation quinolones. Third generation quinolones exhibit sec-
ond generation skeleton in addition to a variation in the substituent groups R1, R2 and R3 and the
atom X8. There are no general requirements to take into consideration.
Ofloxacin (Oflo), used in this thesis, is a second generation fluoroquinolone and containes R1 =
CH(CH3)CH2O (with the oxygen attached to the carbon X8), R7 = methylpiperazine, R6 = fluo-
rine, R5 = hydrogen and X8 = carbon. The chiral centre in the R1 substituent (marked by * in figu-
re 3.1) gives rise to two distinct isomeres.
3 Antimicrobial chemotherapeutic agents are said to be broad when they act on a large range of both Gram negative and Gram positive
microbes, narrow when they act on mostly Gram negative or Gram positive microbes and limited if they act on a single microbe.
a)
b) c)
Figure 3.1 a) Quinolone-skeleton b) Nal c) Oflo
Theory - Part B: The antimicrobial quinolones
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Quinolones can be classified into four generations based on their antimicrobial activity. The term
“generation” does not reflect the time of discovery. Levofloxacin, the most active isomer of Oflo,
is considered a third generation quinolone whereas the rasemic mixture Oflo is classified as a sec-
ond generation quinolone.
The development of new fluoroquinolones is a continuously growing field even today.
Fluoroquinolones are highly active against both Gram negative and Gram positive bacteria and
some other microbes as well. Their structures allow excellent tissue penetration and a great bio-
availability.
3.3 Ofloxacin
(±)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido [1,2,3-de] [1, 4]
benzoxazine-6-carboxylic acid is usually called Ofloxacin (Oflo) and has the molecular formula
C18H20FN3O4. It acts as a zwitterion (as most quinolones) at physiological pH. The pKa valu-
es are 6.05 (pKa1) and 8.22 (pKa2)[5].
Oflo was first patented in Europe for medical use by  Daiichi (Eur.pat. appl. 47,005) in 1982 and
the first article focusing on the drug was published in 1983. In 1987 Levofloxacin (Levo), the most
active isomer of Oflo, was patented for medical use by Daiichi (Eur.pat. 206,283). Oflo, together
with Ciprofloxacin (cipro) are the only second generation quinolones still in medical use today.
Oflo is considered soluble in aqueous solutions at pH 2 - 5 and sparingly to slightly soluble at pH
7 (4mg/mL). In aqueous solutions above pH 9 it is regarded freely soluble as defined by USP
nomenclature[6].
Both the methylpiperazine and carboxylic substituents are expected to have free rotations around
the C7-N and C3-C11 bonds in solution. The rotation of methylpiperazine is investigated in this
Figure 3.2 Levofloxacin (Levo) is the most active isomer of Oflo
Theory - Part B: The antimicrobial quinolones
20
thesis. Ab initio quantum mechanical calculations by Chidangil et al.[7] have proved that the car-
boxylic group does not exhibit free rotation in the protonated state due to hydrogen bonds bet-
ween the hydroxyl group and O4.
In the deprotonated state Oflo forms chelates to several metal ions, following the order Fe3+ >
Al3+ > Cu2+ > Ni2+ > Pb2+ > Zn2+ > Mg2+ > Ca2+ > Ba2+[6]. The metal coordinates between the
6-carboxylic group and the 7-keto group[8].
Recently, work has been done on enantioselec-
tive binding modes of Oflo to B form DNA
and to various synthetic polynucleotides by
Seog K Kim et al[9,10]. These articles conclu-
de that the R-enantiomer is insignificantly
bound to DNA, inspite of the S-enantiomer
being  strongly binding. The association con-
stant for Oflo-DNA complexation was calcu-
lated at 8.2 * 103M-1 for the S-isomer and esti-
mated to be 3 to 4 times higher than the R-iso-
mer. They concluded that Oflo is propably
interacting with DNA as described in the
Nordén model (see chapter 3.4.3), and that the
binding geometry is similar for both enantio-
mers.
When investigating binding of R- and S-Oflo to polynucleotides they discovered that the R-
isomer is selective towards GC base pairs and confirmed that the S- and R- isomers exhibit simi-
lar binding geometry, namely possible partially intercalating in the minor groove.
Little work has been done on Oflo using NMR, but in 1996 Mucci et al. reported structural pro-
perties of Oflo applying both 1H-NMR, NOE and 1H, 13C inverse detection NMR through
heteronuclear multiple-quantum (HMQC) and multiple bond (HMBC) techniques[11]. The spec-
tra were obtained at 300K using DMSO-d6 as solvent. Interestingly, they concluded that the flu-
orine has four and five bonds long-range coupling to the 2´ and 6´ protons mainly distributed
through space.
3.4 Mechanisms of action
Fluoroquinolones display essentially two different mechanisms of action when interacting with
DNA, either targeting the DNA gyrase enzyme or the topoisomerase IV enzyme. Mainly, the
DNA gyrase is attached in Gram negative and topoisomerase IV in Gram positive bacteria. Both
procedures prevent cell reproduction by stopping DNA replication which can lead to cell death.
Since Oflo is a narrow range antimicrobial agen acting mainly on Gram negative microbes, the
Figure 3.3 Oflo chelating with Al3+[8]
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focus will be on DNA gyrase inhibition.
The DNA gyrase enzyme is essential to all organisms with supercoiling of the DNA strand being
essential for transcription. The gyrase enzyme is built up by two gyrA and two gyrB sub-units in
a A2B2 tetramer. The Tyr-122 site in gyrA is considered the active site in DNA cleavage.
The enzyme cleaves the DNA helix, allows another part of the DNA  to pass through a DNA-
”gate” created by the enzyme and closes the gate again. In order for the DNA gyrase enzyme to
function it recuires ATP as an energy source and Mg2+ ions for DNA cleavage.
Figure 3.4 The DNA gyrase cyclus[12]
a) Gyrase binds to the DNA as a tetramer and wraps the segment as to induce a positive supercoil in the helix.
This leads to a cleavage of the DNA strand and a “DNA gate” is produced (G-segment in figure).
b) When gyrase binds to DNA conformational changes are introduced. The gyrase traps another segment of the
DNA (T-segment in figure)
c) The gyrase leads the T segment through the opening in the G segment 
d) The “DNA gate” is closed in the G segment and the process is over. A supercoil has now been introduced in
the DNA helix.
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The cleavage of the helix has been proposed to be sequence specific. In 1979 Morrison and
Cozzarelli[13] showed that the gyrase cleaves the DNA four bases appart, one strand in 5´ posi-
tion and the other in 3´ position. The strand being cleaved in 5´ position is always attacked bet-
ween a G and a T.
The DNA gyrase is considered the target for quinolone activity. The detailed mechanisms, howe-
ver, are still discussed. It is known that DNA gyrase and the quinolone form a ternary complex.,
but it is not known in what order the complex is formed. Is quinolone interacting with DNA and
then gyrase? Does the quinolone interacts first with gyrase? It is also a possibility that DNA and
gyrase interact before quinolone and complex. Is the complex stable or does it dissolve?
Many questions are still to be answered and many theories have been proposed. Up to 1985, the
general opinion was that quinolones are binding directly to the DNA gyrase, since the quinolones
prevent the action of the enzyme.
In 1985 Linus L. Shen and Andre G. Pernet[14] reported that Norfloxacin (Nor) was binding to
DNA and not gyrase as previously anticipated. Nor was even binding at a higher magnitude to
singelstranded DNA (ss-DNA) than double stranded DNA (ds-DNA). A new paradigm was cre-
ated in quinolone research. The view of Shen and Pernet dominated the reseach area for the next
decade, and only in the past ten years has this model been challenged.
3.4.1 The Shen model
Shen et al.[15] presented a model in 1989 for the binding of quinolones to DNA, followed by a
number of supporting articles[16,17,18]. On the basis of work done by Shen and Pernet in 1985
and a number of available evidence found by others they suggested what is now called the Shen
model.
Figure 3.5 The interaction of quinolones in DNA gyrase. Four quinolones are binding in DNA (square
boxes) on the four single stranded base pairs from each strand[15].
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The gyrase interacts with DNA by cleaving one of the DNA strands and leaving four bases unpai-
red on each strand. Before the DNA supercoils and the bases pair again, quinolone will interact
with one of the single-strand fragments. The first quinolone molecule interacts with DNA for-
ming hydrogen bond (s). This allows the next quinolone to bond with both DNA and the first
quinolone making it a cooperative process. A total of four quinolone molecules will interact in
this way, stabilising the gyrase-DNA complex preventing the enzyme from moving further.
The four quinolones are interacting with each other resulting in further stabilisation of the com-
plex. The two molecules bonding to the same DNA strand are oriented so that the 4-keto groups
of both molecules point in the same direction. This allows for stacking. The two quinolone mole-
cules at each DNA strand interact tail-to-tail with the other two molecule through hydrophobic
interactions.
Experimental results reported after the proposal of this model are usually either pro or contra the
Shen model.
3.4.2 The Maxwell model
In 1993 Maxwell and Willmott[19] discovered that quinolones only bind to the gyrase-DNA com-
plex and not to gyrase or DNA alone.
In 1996 Maxwell and Critchlow[20] showed that the single strand fragments, as generated by the
Figure 3.6 The quinolones stabilise the complex by stacking and tail-to-tail hydrophobic interactions[15]
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DNA cleavage, are not necessary for quinolones binding to the complex as Shen proposed. This
led Maxwell and Kampranis two years later to propose a different mechanism for quinolone-DNA
interaction[21].
When DNA interacts with gyrase a certain unwinding occurs. This generates a DNA-”bubble”
where some of the base pairs in the DNA helix no longer pair (see figure 3.7, lower part). Quinolones
then intercalate between the base pairs flanking this DNA-”bubble”, making the DNA strand
unstable, and will eventually lead to cleavage of the DNA strand at one side. The cleavage of one
strand then makes the DNA more unstable, inducing even faster cleavage of the second strand.
The Maxwell model clearly states that DNA cleavage is  a result of, and not an essential require-
ment for, quinolone activity.
Experiments with Ca2+ also suggested that drug-induced cleavage is only occuring when the
appropriate DNA base sequence exists at the active site.
3.4.3 The Nordén model
Two other groups that have done substansial work on quinolone activity is one South Korean (Son
et al.) and one Swedish group (Nordén et al.). Together they investigated the angles between
quinolone and DNA in a quionolone-DNA complex at different temperatures[22]. They found
that quinolone was interacting with DNA without the presence of gyrase or ATP. They also dis-
Figure 3.7 Quinolones interacting with DNA makes the DNA-gyrase complex unstable utilising cleavage of
the DNA double helix[21]. 
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covered that the quinolone was complexating with DNA without the presence of metal ions and
that it interacted both with DNA as single stranded and as a double helix. All this is contrary to
earlier reports written by both Shen and Maxwell.
From their results they excluded both minor groove binding and surface binding and concluded
with only one binding site. They also found that DNA is deformed at the binding site.
The classical intercalating mode would not deform DNA, so they proposed a intercalating mode
of action followed by a deformation of the DNA, bending the helix near the binding site. The
model proposed is not in coherence with the Shen model or the Maxwell model.
3.4.4 Metal ion based models
Many models take the stand that metal ion presence (preferably Ca2+ or Mg2+) is necessary to
explain the quinolone action.
Palú et al.[23] published in 1992 a paper where they found that Mg2+ played an important part in
quinolone-DNA interactions. From experimental results they concluded that Mg2+ present at
moderate concentrations was important to the reaction mechanism.
The model proposed that a Mg2+ ion act as a bridge between the phosphate groups of the nucleic
acid and the carbonyl and carboxyl moieties of the quinolone. Additional stabilisation may origi-
nate from the stacking interactions between the condensed rings of the quinolone and DNA
bases.
Another group, Kervin et al.[24], proposed a complexation of 4:4 of quinobenzoxazine:Mg2+.
Quinobenzoxacine (QB) is a quinolone related antitumour drug. This complex is formed when
one drug molecule is intercalated into DNA and a second molecule is bound externally, held to
the first molecule by two Mg2+ bridges. Two such heterodimers form the 4:4 complex in which
the two externally bound molecules interact via pi-pi interactions.
Further experiments led to a proposal of a model for quinolone activity resembling the model by
Palú et al., but they suggested that partly unwinded double helix must be the likely target action
site rather than the unwinded single strands.
Kervin presented a model where a quinolone intercalated into DNA in the partially unwinded
double helix (due to gyrase) and another quinolone molecule bound externally to the first with
two Mg2+ form a bridge, as with QB. There is also the possibility of forming a 4:4 complex as
with QB.
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3.4.5 Other models
In 1998 Bailly et al.[25] reported a sequence-dependent GC cleavage of DNA with interaction
with quinolones. A quinolone was found to form intercalation complexes with DNA , preferably
with GC sequences under low ionic strength conditions. No distinct conclusions were suggested
what concerns binding mode, since substitutions in either the minor or major grooves of the dou-
ble helix interfered with the binding reaction.
Figure 3.8 Stereoview of the model proposed by Kerwin et al. QB partially intercalating and partially binding to
the surface complexating with Mg2+ in a 4:4 ratio[24].
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In the history of science, the Nuclear Magnetic Resonance (NMR) technique is fairly new. In
1946, two separate groups led by Felix Bloch and Edvard Purcell both discovered and developed
the technique. For their work Bloch and Purcell shared the Nobel Prize in physics in 1952.
At first NMR was a method used solely by physicists. Later several other groups discovered the
advantages of NMR, including chemists, biochemists and medicins. Today the NMR technique is
an important tool for all of these groups and NMR experiments are carried out on a routine basis.
Advancements in the utilization of instrument, software and techniques together with the con-
stant improvement in computational power drive the knowledge on the field further onwards.
One of the milestones in the development of the NMR experiment was the introduction of the
“Fourier Transform (FT) Spectroscopy” in 1970. Previously the only method available was the
“Continuous Wave (CW) Spectroscopy”. The FT-spectroscopy method shortened the experiment
timespan, enhanced both sensitivity and resolution and made it possible to use small samples in
the experiments. But the greatest advancement was perhaps the possibility of utilizing several
dimensions.
The application of NMR-techniques makes it seemingly easy to study the magnetic properties of
atomic nuclei and their relative position in the molecule. One of the greatest advantage of NMR
compared to other methods, like x-ray crystallography, is that even large molecules will give high-
resolution data in solution.
4.1 Basic theory
The physical basis of the Nuclear Magnetic Resonance (NMR) experiment is the nuclear angular
momentum P. That is, most nuclei are assumed to be spherical and rotating about its own axis
producing an angular momentum. According to quantum mechanical considerations, quantized:
where P is the nuclear angular momentum, I is the angular momentum quantum number (often
called the nuclear spin) and h is Plankcs constant equal to 6.6256 * 10-34 J s
The nuclear spin I may have the values 0, 1/2, 1, 3/2, 2, …up to 6. The angular momentum is
associated with a magnetic moment mu, both being vector quantities and proportional to each
other (see equation 4 - 2).
4. Nuclear Magnetic Resonance
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P = (I(I+1))1/2 (h/2S)                                   4 – 1  
The proportionality factor gamma is a constant for the isotope of each element and is called the
magnetogyric (or gyromagnetic) ratio. Nuclides with small gammas are said to be insensitive, mea-
ning difficult to observe, whereas nuclides with large gammas are the opposite. By combining
equations 4-1 and 4-2 we get another expression for mu:
Nuclides with I = 0 have no nuclear magnetic moment and cannot be observed in NMR experi-
ments. Important examples are the main building blocks of organic compounds 12C and 16O.
Nuclides with spins have a non-spherically shaped charge distribution making them behave sim-
milar to bar magnets in an external magnetic field. These bar magnets will then have 2I+1 pos-
sible orientations in the magnetic field. Nuclides with an odd mass number has I values 1/2, 3/2,
5/2, and so on.
Table 4.1: Spin (I) and natural abundance for some nuclides
For most nuclides the nuclear angular momentum vector P and the magnetic moment vector mu
point in the same direction. However, in a few cases they are anti-parallel as in 15N and 29Si and
even in the electron.
4.2 Energy levels
If a nucleus with I > 0 is placed in a static magnetic field B0, the z-component of the angular
momentum will take one of the orientations given by:
Theory - Part C: Nuclear Magnetic Resonance
29
P = J P        4 – 2 
P = J (I(I+1))1/2 (h/2S)      4 – 3  
Nuclide
1H
2H
12C
13C
14N
15N
16O
17O
Spin
1/2
1
0
1/2
1
1/2
0
5/2
Natural abundance (%)
99.985
0.015
98.9
1.108
99.63
0.37
99.96
0.037
Table content adapted from ref[25]p3.
Pz = m * h/2S        4 – 4  
where m is the magnetic quantum number defined by I (m = I, I-1....-I+1, -I), hence the 2I+1
possible orientations. From equations 4 - 2 and 4 - 4 we get the z-component of mu in the field:
The energy of the magnetic momentum in the field is given by:
where B0 is the flux density of the applied magnetic field. For a nuclei with 2I+1 possible orien-
tations there will be 2I+1 energy states called the nuclear Zeeman levels. From equation 4 - 5 we
find that:
For nuclei with I = 1/2 (i.e. 1H and 13C) two possible orientations exist (2I+1 = 2) and two nucle-
ar Zeeman levels:
and
In quantum mechanics the m = +1/2 state is described by the spin function alpha and the m = -
1/2 state is described by the spin function betha, therefore it is common to use alpha and betha
as labels instead of m = ±1/2.
Theory - Part C: Nuclear Magnetic Resonance
30
Pz = m J h/2S        4 – 5  
E = -Pz B0        4 – 6
E = - (m J h/2S) B0       4 – 7 
Em=+1/2 = -(1/2 J h/2S) B0      4 – 8   
Em=-1/2 = (1/2 J h/2S) B0      4 – 9  
Figure 4.1 Energy levels for nuclei with a) I = 1/2 and  b)I = 1 [25]p5.
a) b)
The energy difference between two adjacent nuclear Zeeman levels is:
4.3 Populations and precession
One never looks at single nuclei, but rather populations of a nuclei. There is always a distribution
of the population along the energy levels and the lowest energy level is slightly more populated.
In the case of investigating a nucleus with I = 1/2 there are two different energy levels, hence two
populations Nalpha and Nbetha (using the labelling described earlier). The distribution of nuclei bet-
ween the energy levels follows the Boltzman distribution law, which gives the following relation-
ship:
which can be simplified to:
where kb is the Boltzman constant equal to
1.3805*10-23JK-1 and T is the absolute temp-
erature in Kevin. The population in the lowest
energy level is Nalpha. Similar calculations can
be outlined for nucleus with I other than 1/2.
For all nuclei the energy difference, delta E,
will be small compared to the energy of the
thermal conditions kbT and the difference of
populations in Nalpha and Nbetha is in the region
parts per million. This is one of the reasons
why NMR is a rather insensitive method and
the electronics and other equipment must be
equally sensitive to get good results. One way
to increase the sensitivity is to use a higher magnetic field to increase the difference between the
energy levels.
The classical representation of a nuclear dipole precessing around a z-axis would resemble that of
a spinning top. In contrast to the spinning top, however, the nuclear dipole must keep within the
energy level such as only certain angles are allowed. For a nuclide with I = 1/2 this angle is 54°44’.
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'E = J (h/2S) B0       4 – 10  
NE/ND = e
-'E/k
b
T        4 – 11  
NE/ND | 1-('E/kbT) = 1 – (J (h/2S) B0/kbT    4 – 12  
Figure 4.2 The cone distribution of magnetization vec-
tors[25]p6.
The precession frequency, also called the Larmor frequency, nuL is proportional to the magnetic
flux density B0:
When populations precess at different energy levels there will be a resulting macroscopic magne-
tization vector M0. Further discussions will be referring to the macroscopic magnetization vector.
4.4 Resonance, shielding and the internal scale
If a radio frequency signal is applied to the system the relationship between the populations will
alter so long as the radio signal frequency matches the frequency the nuclear magnets naturally
presess in the magnetic field. This is called resonance.
According to quantum mechanics only those energy level transitions in wich the magnetic quan-
tum number m changes by a single quantum are allowed:
Therefore the only transitions allowed are between adjacent energy levels. The energy of a radio
signal can be given by:
Equation 4-10 expressed the energy difference between two adjacent energy levels. Combining
equations 4-15 and 4-10 will lead to the resonance condition:
which also equals the Larmor frequency (equation 4-13). The resonance arising from each nucli-
de is influenced by the chemical environment of the nuclei allowing separate observations. The
electrons surrounding the core will, because of the applied magnetic field B0, induce a current,
which sets up a magnetic field B in the opposite direction of the applied magnetic field thus redu-
cing the field experienced by the nucleus. This is called shielding. The effective field experienced
by the nucleus is given by:
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'm = r 1        4 – 14  
E = hQ         4 – 15  
Q = JB0/2S        4 – 16  
Beff = B0 – B' = B (1 - V)      4 – 17  
QL = |J/2S| B0       4 – 13 
where s is the shielding constant, a molecular, dimensionless constant independent of the mag-
netic field, determined solely by the electric and magnetic environment of the nuclei in question.
The resonance condition now becomes:
meaning that nuclei with different shielding constants, s, will resonate at different frequencies and
thus are possible to separate.
But absolute frequencies are difficult to measure. To obtain such frequencies would demand ex-
tremely stable magnets. It would also mean that magnets of different strength would give different
results and there would be a need for several frequency lists for every magnetic strength in order
to compare results. An internal standard is introduced to avoid these problems. Most common as
an internal standard is Tetramethylsilane (TMS). It is applied in most 1H and 13C NMR ex-
periments today. To avoid the dependencies on the magnetic field strength, one introduced the
chemical shift, little delta, defined as:
The factor 106 is introduced to simplify the numerical values. The chemical shift is really a
dimensionless value, but because of the factor 106 one commonly refers to chemical shift values
as part per million (ppm). The definition of the chemical shift requires that the absolute frequen-
cy of TMS has to be measured every time. To avoid this, one introduced the observing frequency
instead:
TMS, the internal standard, was chosen as a standard because it contained the least shielded pro-
tons known at that time. Today protons with less shielding are known, giving negative chemical
shifts.
4.5 The pulse
There are in fact several ways to carry out an NMR experiment. In the early stages of NMR there
were two ways to obtain an NMR spectrum; variating the field with radiation of a constant fre-
quency pulse or variating the puls in a static magnetic field. Both these methods “screen” the sam-
ple and the result are written out as the experiments proceeds. This is the Continuous Wave (CW)
Spectroscopy described earlier in this chapter. The method requires a sensitive nucleus and a high
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Q1 = (J/2S)(1-V)B0       4 – 18  
G = ((Qsample - Qreference) / Qreference) * 106     4 – 19  
G = ('Q/observing frequency)*106     4 – 20  
concentration of the sample. The first method also requires a magnetic field that can be varied. It
can only be obtained for low fields, thus the insensitivity of the method. The most common met-
hod today is the Pulsed Fourier Transform (PFT) Spectroscopy using a static magnetic field. This
is the method described further on in this text.
All the nuclei of the species in question are simultaneously excited by a radio frequency pulse in
the PFT method. Although, as seen in the earlier chapters, all of the nuclei do not reach the re-
sonance condition at the same frequency the pulse is constant at a fixed frequency nu1. What
makes this possible is the time span. When the pulse is set on and shut of there is a short period
where the frequency is not constant. When the pulse is switched on  only briefly, taup being in the
order of ms, this results in a pulse with a continuous band of frequencies symmetrical around the
centre frequency nu1 rather than just the set frequency. Approximately only taup-1 of the frequency
band is effective in exciting transitions. The choice of the frequency nu1 is determined by B0 and
the nuclide to be observed and the duration of the pulse is determined by the width of the spec-
trum.
Short pulses with high power, “hard pulses”, are used to radiate all nuclei simultaneously. The
duration of the pulse is then chosen so the frequency bandwidth exceeds the width of the spec-
trum by one or two powers of ten, typically
several watts.
4.6 The pulse angle
At equilibrium, the nuclear moments precess
with the Larmor frequency on the surface of a
cone (see figure 4.3) and as a result  a magne-
tization vector M0 occurs in the same direction
as the field. To induce transition, the radio fre-
quency pulse is sent in along the x-axis. The
magnetic vector of the electromagnetic radiati-
on can thus interact with the magnetic vectors
of the nuclei, changing the magnetization vec-
tor M0. The magnetic field from the radio fre-
quency pulse is alternating: Picture two mag-
netization vectors with the same magnitude,
B1(r) and B1(l), but in opposite directions.
These two vectors both precess with the Larmor frequency giving a resultant vector along the x-
axis direction that alternates between 0 and 2B1.
Only one of the two magnetization vectors from the pulse has the same direction of rotation as
the precessing magnetization vectors from the nuclei. This is the only magnetization vector from
the pulse able to interact with the nuclei. From now on this vector will be refered to as B1.
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netizationvectors from the nuclides[25]p10.
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Under the influence of B1, M0 rotates from the z-axis in a plane perpendicular to the direction of
B1. However, since B1 rotates with the Larmor frequency, this is rather difficult to illustrate. A
new coordinate system x´, y´ and z where x´ and y´ rotates with the same frequency as B1 is defi-
ned to simplify this. The orientation and magnitude of B1 in this system will now be fixed, and M0
is tipped about the x´ axis by B1. The magnetization vector M0 is tipped by an angle, tetha,
depending on the amplitude B1i of the component of the radio frequency pulse at the frequency
nui of the nuclear resonance transition, the nucleus in question and the length of time for which
the pulse is applied:
Pulses are named after the angle of which they rotate M0.
As seen in the figure, the transverse magnetization vector My´ is at a maximum immediately after
a 90x´° pulse and 0 immediately after an 180x´° pulse, hence the best signal is achieved using a 90x´°
pulse.
4.7 Relaxation
The pulse rotates the magnetization vector away from equilibrium through an angle Q. M0 now
deflects around the z-axis described by its components Mx, My, and Mz, which vary with time, t.
After the pulse is switched off the spin system will return to its original equilibrium through rela-
xation. This process may last from milliseconds to hours. There are two different relaxation pro-
cesses: Spin-lattice relaxation along the direction of the applied magnetic field and spin-spin rela-
xation perpendicular to the applied magnetic field.
4.7.1 Spin-lattice relaxation
The rate of wich the relaxation along the direction of the applied magnetic field leads is determi-
Theory - Part C: Nuclear Magnetic Resonance
35
4 = J B1i Wp        4 – 21  
Figure 4.5 Flipping of a magnetization vector from an arbitrary angle pulse, 90-degree pulse and 180-degree
pulse[25]p11. 
ned by the spin-lattice relaxation time, given by the time constant T1. Felix Bloch described this
process with the Bloch equation for spin-lattice relaxation:
This is considered to be a first order process giving T1-1 as the rate constant for the relaxation. The
time constant T1 is usually not recorded for 1H under high-resolution NMR conditions, since in
most cases they are of the order of milliseconds. 13C on the other hand has greater variation of
T1, ranging from a few milliseconds in large molecules to several minutes in small molecules.
Spin-lattice relaxation is associated with an energy change in the spin system. The radio frequency
pulse has excited the spin system which now will exchange energy with the surroundings through
emmition in the relaxation process. The energy is transported to neighbouring molecules or even
the wall of the vessel - the lattice in general, thereby increasing the thermal energy of the lattice.
Different intra- and intermolecular interactions contribute to the spin-lattice relaxation and the
mechanisms can be classified as:
- Dipole-dipole relaxation (dipolar relaxation)
- Spin-rotation relaxation
- Relaxation through chemical shift anisotropy
- Relaxation through scalar coupling
- Electric quadrupolar relaxation
- Relaxation through interaction with unpaired electrons in paramagnetic compounds.
The main source of spin-lattice relaxation for 13C nucleus is dipole-dipole coupling, which can be
measured directly through the Nuclear Overhauser Effect (NOE, chapter 4.9). Dipole-dipole rela-
xation is also the most important process studied and the only relaxation mechanism this text will
concentrate on.
Interactions between nuclear dipoles arise from the fact that every nucleus is surrounded by
moving magnetic nuclei in the same or neighbouring molecules. This motion sets up fluctuating
magnetic fields around the nucleus in question. The frequency band is relatively broad and large-
ly dependent on the viscosity of the solution. These fluctuating magnetic fields are able to induce
nuclear spin transitions if they possess the right frequency.
The theoretical description of dipolar relaxation for an assembly of molecules leads to the pro-
portional relationship between T1 and tauc  formulated in the following rule: The faster a molecu-
le moves, the greater is T1. Here tauc is the correlation time, corresponding roughly to the interval
between two successive reorientations or positional changes of the molecule, by either vibration,
rotation or translation. The dipole-dipole relaxation mechanism is especially effective when the
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dMz/dt = -(Mz-M0)/T1      4 – 22  
carbon nucleus in question is directly connected to one or more hydrogen atoms.
4.7.2 Spin-spin relaxation
Immediately after a 90x´° there are components of the magnetization vector in the x´ and y´
planes, Mx´ and My´. These magnetization vectors are due to the fact that all the nuclei´s magneti-
zation vectors are not uniformly distributed in the cone energy level. This is called phase co-
herence (see figure 4.2)
As these nuclear magnetization vectors fan out the resultant magnetization, vectors Mx´ and My´
are eliminated. This process is described by the Bloch equation for spin-spin relaxation:
and
The time constant T2 is called the spin-spin or transverse relaxation time. No energy is lost during
spin-spin relaxation, only the phase coherence between the precessing nuclear spins is lost, and
the level populations will not change due to this relaxation, which is the reason why this type of
relaxation sometimes is being referred to as an entropy process.
The main contribution to the spin-spin relaxation comes from B0 not remaining homogeneous
throughout the volume of the sample. These inhomogeneities even cause nucleus with the same
chemical environment to precess with slightly different Larmor frequencies. When some nucleus
precess slightly slower and some slightly faster than the Larmor frequency, it will result in the fan-
ning out ending with the elimination of the macroscopic magnetization vectors.
T2 is related to the line width of the observed NMR signal and this is the main practical signifi-
cance of this time constant. The relationship is given by:
It is possible for the transverse magnetization My´ to decay completely before the longitudinal
magnetization Mz has reached equilibrium, but it is not possible for the longitudinal magnetizati-
on to reach equilibrium before the transverse magnetization has completely disappeared. As a
result of this, T1 must always be larger or equal to T2.
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4.8 The Free Induction Decay (FID)
As mentioned earlier the signal registered in the apparatus arises from the magnetization in the
x´y´-plane. The relaxation of these magnetization vectors induces a signal picked up by the re-
ceiver coil in the apparatus. This results in a decaying time dependent signal. This signal is called
the Free Induction Decay (FID), it contains all the information from the sample but is rather hard
to analyse directly. The FID is therefore Fouriere Transformed to obtain a frequency dependent
spectrum which is possible to analyse.
The Fourier transformation is described mathematically by:
and this is the mathematical basis of the Fourier Transform (FT) NMR method.
4.9 1D 1H NMR
The sample is placed in the probe-head and the magnetic field surrounding the sample made as
homogenious as possible through shimming. Shimming is the adjustment of several circuits to set
up an additional magnetic field inside the magnet correcting the original field. The macroscopic
magnetization vector M0 is oriented along the field B0 at equilibrium. When applying the radio fre-
quency pulse, M0 is rotated to an angle depending on the pulse length, tD. As long as no long rela-
xation times or other time requirements exist to make it impossible, tD is usually chosen to rotate
M0 90° and thus maximizing the signal output.
This results in  Mz = M0 = 0 and My = M0. The receiver coil then register the decay of My and Mx
and the FID is obtained. After a Fourier Transformation of the FID, the 1D NMR spectrum is
ready to be investigated.
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F(Q) v ³f-f f(t)e-i2
SQtdt       4 – 26 
Figure 4.6 From FID to specrum by Fouriere Transformation[26]p26.
4.10 Nuclear Overhauser Enhancement (NOE)
The NOE effect increases the intensities of the signals. Two nuclei close in space exhibiting a
dipolar coupling will help each other to relax. The NOE effect works through space, not neces-
sarily through scalar couplings. The system for two dipolar coupled nuclei A and X with no sca-
lar coupling is illustrated below:
During excitation the only allowed transitions are delta m ± 1 (equation 4 - 14). During relaxati-
on this is not the case. Figure 4.6 describes the possible pathways for relaxation. W2 is a double
quantum transition and W0 a zero quantum transition. W0 and W2 are determined mostly by dipo-
le-dipole relaxation. When non-dipolar mechanisms are relaxing the system, this affects mainly W1.
Irradiation of the sample with the resonance frequency of A equalizes (i.e. saturates) the popula-
tions in the N1-N3 and N2-N4 levels. The population difference for X has not changed and there
seems to be no signal enhancement.
The irradiation shifts the system out of equilibrium, and because the W1A pathway is irradiated
and the W1X has not changed from equilibrium, the only pathways to relaxation are W0 and W2.
When relaxation along W0 occurs, populations in N2 are increased and N3 decreased, thus redu-
cing the difference in populations N1 - N2 and N3 - N4, thereby reducing the signal intensity from
X. Relaxation along W2, on the other hand, increases population N1 at the expense of N4, see-
mingly increaseing the difference between populations N1 - N2 and N3 - N4 giving enhanced sig-
nal intensity from X. As NOE is a relaxation process it needs some time to build up.
The system is not relaxed by W0 or W2, but the two pathways in combination. Both W0 and W2
relax the system and are therefore competing pathways. What decides whether W0 or W2 domi-
nates in the relaxation process is the correlation time, tc. Small molecules tumble faster than large
ones and thus have shorter tc. W2 dominates at short correlation times and W0 at long correlation
times. Thus, small molecules give positive NOE effect and large molecules give negative NOE
effect.
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Figure 4.6 Two nuclei A and X (illustrated with H and C) are dipolar coupled and help relax each other
through the pathways W0 and W2. The usual relaxation pathway W1 is irradiated[26]p74. 
(N1)
(N2)
(N3)
(N4)
The frequency of the applied magnetic field is also an important factor. The fluctuating magnet-
ic fields needed to induce the double quantum transition must contain frequencies close to the
sum of the Larmor frequencies of A and X. The zero quantum transition requires much lower
frequencies. Thus it is more likely to find negative NOE amplifications in a high field.
The NOE effect will also depend on the distance between the cross-relaxing molecules and will
decrease in inverse proportion to the sixth power of the distance. This is an important tool for
calculating distances between molecules through space.
Maximum NOEs cannot be achieved, since the dipole-dipole relaxation process is not the only
process relaxing the nuclei. In theory the maximum NOE intensity enhancement is given by:
The maximum NOE effect for a 13C signal coupling with 1H is roughly 3. In comparison, the
maximum NOE effect for 1H  relaxing with 1H is only 1.5, since gammaX and gammaA will be
equal.
4.11 NOESY
NOESY (Nuclear Overhauser Enhancement Spectroscopy) is a 2D NMR technique mainly used
to determine structures of larger molecules in solution. There is a relation between the cross peak
volume aij and the distance between spin nuclei i and j for larger molecules with short mixing
times:
Hence the cross peaks will contain information about the distance between nuclei coupling
through space. The pulse sequence for a NOESY experiment is given below:
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Dij v 1/(rij6)        4 – 28  
Figure 4.7 The pulse sequense for a simple NOESY experiment[26]p111. The sequence shown is simplified
compared to the sequence used in experiments in this thesis.
K + 1 = 1 + ½ * JX/JA      4 – 27  
A simple 1H 1D NMR experiment is built up with just one pulse and then the acquisition. 2D
NMR experiments are a little more complicated. To build in the second time dimension there is
an incrementing time delay between the two pulses. The first pulse flips the magnetization vector
into the xy-plane. Then, because of the time delay, it fans out from the slightly different Larmor
frequencies. The time delay should not be long enough for any T1 relaxation to occur. The sec-
ond pulse will flip the magnetization vector in the opposite direction of the magnetic field giving
zero signal. But, a component of the magnetization vector is on the x-axis during the second
pulse because of the fanning out. This component is not rotated by the second pulse, giving rise
to a signal containing information from both time dimensions.
In this thesis NOESY is applied to confirm that the DNA sequence is a duplex and not just sing-
le stands and to check the conformation of the oligomer after interaction with Ofloxacin as well
as to see where Ofloxacin is interacting.
4.12 Water suppression
Water is a frecuently used solvent. Given the high concentration of 1H in water, 55M, there is a
relatively large signal due to water protons, considering the sample concentrations are between
0.07 mM and 6 mM. This results in baseline distortions and makes it difficult to observe other sig-
nals in the same vicinity to the water proton signal. To avoid this problem water suppression met-
hods are used.
Water is either suppressed by presaturation of the water signal before aquisition or the pulse-
trainesWATERGATE (WATER GrAdient Tailored Excitation) sequence w5 or the sequence 3-9-
19 are used to manipulate the magnetization vectors as to minimise the water signal.
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Traditionally, self-diffusion constants have been measured through radioactive tracing techniques.
These methods still give the most accurate data available experimentally today, but they are rather
time consuming and complicated. Self-diffusion constants measurements obtained by NMR tech-
niques require no specific sample preparation and demand no more time than other NMR expe-
riments. NMR techniques can provide individual multicomponent self-diffusion constants with
good precision.
Self-diffusion measurements have been utilised ever since the discovery of spin echoes, and
during the last three decades the technique has been heavily used to investigate molecular trans-
port. The theory is well known and a number of good reviews including theory and application
have been published[27, 28, 29, 30].
5.1 Diffusion
Diffusion is defined as random motion in space. Molecules in solution are constantly in motion
both rotationally and translationally. The process of translational motion are referred to as self-
diffusion and is defined with a self-diffusion coefficient D (m2s-1)
The self-diffusion coefficient depends on molecular properties such as size, shape, mass and char-
ge. It also depends on environmental factors like viscosity of solution, temperature, solvent and
other solutes. The concentration becomes a factor if the distant between two molecules are less
than the distance one of the molecules travel in a given time. The concentration is usually not con-
sidered to be a factor.
The Stokes-Einstein equation is a special case of the Debye-Einstein equation and ideal for illus-
trating the relationship between the diffusion constant and the molecular properties. Stokes-
Einstein is referring to spherically shaped molecules.
where D is the self-diffusion constant, kB is the Boltsman constant, T is the temperature and fT is
the friction constant.
where h is the viscosity and RH is the radius of the molecule.
5. Diffusion
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Debye-Einstein:   D = kBT/fT   5 – 1  
Stokes-Einstein:   D = kBT/6SKRH  5 – 2  
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From equations 5 - 1 and 5 - 2 one can see that the self-diffusion coefficient can be found from
the shape and radius of the molecule and the viscosity and temperature of the solution. It also
follows the possibility of knowing the self-diffusion constant of two separate molecules and then
to see from the self-diffusion constant whether two molecules interact in a solution.
5.2 How to measure diffusion by NMR
Diffusion coefficients can be calculated from the echo attenuation if the amplitude and duration
of the magnetic field gradient are known; all NMR diffusion measurements are based on this prin-
ciple.
Which means that there is a connection between the amplitude of the signal and the self-diffusi-
on coefficient. Big delta is the waiting time between the two gradients and little delta the duration
time of the gradient.
All measurements of diffusion coefficients are based on the fact that one can measure the ampli-
tude or the area of the signal-top.
I = I(0) * e - ( D ( J g(i) G ) squ ( '  - G/3 ) 10*4 )     5 – 3   
Figure 5.1 The pulse sequence and the implication of the gradents are shown for a simple spin echo experiment[30].
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5.3 Basic theoretic introduction
Every NMR experiment is based on the repression of the Larmor frequency given earlier by equa-
tion 4 - 13  which may also be expressed as:
Where gamma is the gamma coefficient, a physical quality of the atom in question and B0 is the
strength of the magnetic field (see also NMR theory). One can then influence the system by a gra-
dient given by:
where i, j and k is unit vectors in the x, y and z direction in a Cartesian coordinate system. The
magnetic field exerted on the molecule will then be:
where r describes the position of a specific nuclear spin. The gradient in the z-direction is descri-
bed as:
where k is the unit vector in the z-direction. This gradient gives the nuclear spin-system a phase-
shift theta(z) in the z-direction described by:
z is the distance travelled by the molecule in the time t. The total phase-shift in the magnetic vec-
tors is expressed as:
By exerting the molecules with a gradient pulse for a time, t, one creates a phase-shift. Then, by
exerting the same pulse, but with the opposite direction one can read out the resulting phase-shift.
If the molecules do not move in the waiting time big delta, the second pulse nullifies the effect
g = GBzi/Gx + GBzj/Gy + GBzk/Gz      5 – 5  
B = B0 + g r        5 – 6  
gz = g k        5 – 7  
)(z) = J gz z t        5 – 8  
)(z) total = J B0 t + J gz z t      5 – 9  
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from the first pulse, and no net phase-shift is registered. If, however, the molecule moves a dis-
tance during the waiting time big delta, the second gradient pulse will mere reduce, not nullify the
effect from the first pulse, and a phase-shift can be registered.
5.4 Spin echo or stimulated spin echo
The T2 relaxation of small molecules is slow and using a spin-echo sequence does not cause any
problems, as it may for larger molecules with faster T2 relaxation. Because of the fast relaxation
there will be no information left using a spin-echo sequence. One should therefore use a stimula-
ted spin-echo when the molecule is larger to avoid this problem. Using a stimulated spin-echo
secures that the T1 relaxation dominates allowing faster T2 relaxation.
5.5 Calculations of diffusion constants and association constants
The intensities of the picked peak are plotted as a function of the gradient strength resulting in a
“simfit” plot. The simfit plot is a visual test of the peak attenuation and give an indication on
whether the results are reliable. The uncertainty in the intensity is decreasing with gradient
strength, since the gradient is suppressing more of the peak with increasing gradient strength.
This leads to the conclusion that visual improvement of the simfit plot must be more important
in the high intensity/low gradient strength area of the plot.
There are two ways to derive at the diffusion constants. The most complicated way is to simulate
Figure 5.2 a) schematically overwiev of the self-diffusion experiment b) spin echo pulse sequence, T2 is domina-
ting c) stimulated spin echo pulse sequence T1 is dominating[27].
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a fitness curve on the simfit plot (the name simfit arrives from simulated fitness) using several ite-
rations to best fit the curve. This is done for spin-echo experiment in the t1/t2 part of the
XWinNMR program. The other way is to plot ln Inormalised as a function of X where X is given as:
where g is the gradient strength, gamma is the gradient amplitude, little delta the duration of the
the gradient pulses and tau the delay between the gradients. X is given for a stimulated spin-echo
experiment. This method was applied for stimulated spin-echo experiments as the first spectrum
read by the XWinNMR program repeatedly was destroyed by ringing rendering the possibilities
for peak picking and the intensities had to be read out manually. Also, the equation used in the
t1/t2 program was faulty, as Bruker did not include tau in the calculations. Thus the t1/t2 pro-
gram will calculate invalid results until this fault is corrected.
When ligands interact, the diffusion constants calculated containes an averaged value from both
bound and non bound ligand. The fraction bound ligand (F) may the be calculated from the dif-
fusion constant by:
where D´Oflo and D´GGCC are the self diffusion constants and DOflo are the measured diffusion con-
stant in that experiment. When F is known the association constant can be calculated from:
where COflo and CGGCC are the concentrations of Oflo and GGCC in the sample. The equations
are adapted from reference [31].
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F = (DOflo – D´Oflo)/(DOflo – D´GGCC)      5 – 11
Ka = F/((1-F)*(CGGCC – (COflo * F)))      5 – 12
5.6 Problems
Diffusion measurements are based on the
spin-echo or stimulated spin-echo pulse
sequences and the use of gradient pulses. This
introduces some problems that should be
addressed.
5.6.1 Eddy Current
When gradient pulses are switched quickly on
and off eddy currents are set up to oppose the
change. These currents induce magnetic fields
in the conducting environment of the sample,
as the probe and the magnet. The induced
magnetic fields are slowly decaying, influating
the original magnetic field and introducing
spectral distortion or even changing the positi-
on of the lock signal introducing a shift in the
resonance.
To reduce the effect from eddy currents seve-
ral precautions can be taken. Induced magnet-
ic fields in the inner bore of the magnet can be
reduced by the use of wide bore magnets.
Induced magnetic fields in the probe can be
nullified by a shielded gradient system - a
probe with secondary gradient coils outside
the primary Maxwell pair constructed to pro-
duce a magnetic field identical, but opposite, to
the induced magnetic field. This reduces the
effect of eddy current, but does not solve the problem completely. Experimental techniques to
reduce effects from eddy currents include long waiting time between gradient pulses and design
of pulse sequences that take eddy currents into account. A common way is to apply gradients in
opposite directions using a 180° hard pulse to turn the system.
5.6.2 Gradient Field Nonuniformity
Basic theoretic outlines assume that gradient pulses are uniform across the z-direction of the sam-
ple. Nonuniform gradients will lead to systematic deviations from ideal behaviour and introduce
considerable errors in measured diffusion constants.
One way to reduce the problem is to use slice selection of the gradient pulses, that is, only a small
region of the sample, where the gradient are uniform, are used to obtain diffusion constants. This
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Figure 5.3 Different alternatives to the standard square
gradient. a) trapezoidal b) half-sine shape c) bipolar
gradient composite and d) the CLUB-sandwich inclu-
ding two 180 degree pulses[27].
can either be achieved by physically constraining the sample or exciting only the spins in the regi-
on of the sample where the gradient is uniform.
5.6.3 Temperature Gradients
The heating/cooling system of the magnet designed to keep a constant temperature in the sam-
ple is not optimal. Heating or cooling is either performed from the top of the probe or from the
bottom. This results in a small temperature difference along the z-axis of the sample. Diffusion
is dependent on temperature, hence the temperature gradient will introduce a velocity term to the
diffusion constant.
The problem is difficult to control, but it may be solved by two methods; either reducing the
height of the sample or by using a convection current compensated pulse sequence (a variant of
the double stimulated echo configuration). If the sample height is reduced, the width of the sam-
ple should be reduced first since this has even larger implications.
5.6.4 Other considerations
In addition to the above mentioned problems, there are considerations to take into account during
the aquisition of PGSE NMR data.
As gradients temporarily perturb the field, the lock should be controlled frequently. The data
should preferably be collected in an interleaved manner, to avoid the occurrence of random
errors. Vibrations at the probe are interfering with the diffusion of the molecules in the sample
and ought to be avoided. Small vibrations, from for instance airflow in the probe, as well as che-
mical exchange and cross relaxation may influence the diffusion constant. The general effect from
cross relaxation is that D will change as a function of the diffusion time (big delta) when the sti-
mulated spin echo sequence is used. Spin echo exhibits no such effect from cross relaxation.
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Figure 5.4 Illustration of the 1D profile experiment showing the effect of slice selection[27].
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6.1 Sample preparation
6.1.1 Preparation of the NMR sample of the DNA-oligomer GGCC
The oligomer GGCC delivered was not sufficiently pure, additional purification by HPLC ion-
exchange was therefore needed. The purification was carried out with the eluents A: 10 mM
NaOH, 0.3 M NaCl, pH 12.5 and B: 10 mM NaOH, 1.0 M NaCl, pH 12.5 with a detection wave-
length of 260 nm. A 60 minutes linear gradient run from 100% A to 60% B was applied.
Immediately after purification the oligomer pH was adjusted using a phosphate buffer (NaH2PO4
* H2O). The sample was then desalted by filtration. Purification for paramagnetic impurities was
not conducted.
After purification the sample was freeze-dried and resolved in 450 microL deionised water.
Table 6.1 Description of chemicals
Table 6.2 Description of the equipment 
6. Experimental
Chemical
Oligomer
Phosphate buffer
HCl
NaOH
Sephadex G-25
Deionised water
Deuterated water
EDTA
Purchased/Manufacturer
DNA Technology, Denmark
Merck
Merck
Merck
Barnstead
Cambridge Isotope
Laboratories Inc.
Merck
Description
A palindromic decamer
p.a. quality
For the purification process
For the purification process
Used for desalting
From NANOpure deionising
apparatus
99.9% purity
p. a. quality
Equipment
Pump
Coloumn
FlowDetector
UV-detector
Software
Hardware
UV
Freeze-drying
pH measurements
Purchased/Manufacturer
Waters
Pharmacia Biotech
Waters
Dual
Waters
Pentium
Perkin-Elmer
GENEVAC
Philips
Description
626 LC model
MonoQ HR 10/10
W600s model
W2487 model
Waters Millenium32
ver.3.05.01 software package
Standard PC
Lamda 6 UV/VIS
Spectrophotometer
CVP 100/2 vacuum pump
PW9420 pH-meter with a
Sentron pH ISFET Probe
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To determine the concentration a 5 microL amount of the sample was imbedded in a solution of
500 microL 10 mM phosphate buffer, 500 microL 0.5M NaClO4 and 1000 microL deionised
water. The concentration of the oligonucleotide in the solution was thereafter determined by UV.
6.1.2 Preparation of NMR samples of Ofloxacin 
Ofloxacin was given as the neutral molecule in solid state and no further purification was required.
Two stock solutions of Oflo were made. A series of samples with different concentrations was
prepared from one of the stock-solutions and the other used for titrating GGCC.
First a 7.8 mM stock-solution of Oflo was prepared using stock-solutions of HCl and NaOH to
control pH.
Table 6.3 The making of 7.8 mM stock-solution Oflo*
* pH was measured during the dilution and the final concentration is corrected for volume changes
A series of samples with concentrations ranging between approximately 1 mM and up to 6 mM
was prepared from this stock-solution. Ofloxacin is more easily dissolved at low pH, therefore
HCl was added first followed by NaOH to neutralize the solution.
Table 6.4 Concentration series for measuring stacking of Ofloxacin
These samples were used for measuring stacking of Oflo. The 5.01 M solution was also used for
assignment purposes and for investigating the dynamics of the methylpiperazine ring. A new
stock-solution 5.22 mM Oflo with pH 6.78 was prepared for the titration with GGCC.
Table 6.5 The making of 5.22 mM stock-solution Oflo*
* pH was measured during the dillution and the final concentration corrected for volum changes
** No NaOH was needed for pH correction of the solution
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Oflo
0.0043g
H2O
1280microL
0.05M HCl
200microL
0.05M NaOH
40microL
pH
7.15
Stock-solution
(microL)
65
130
190
250
320
380
Deuterated
water (microL)
50
50
50
50
50
50
Deionised
water (microL)
385
320
260
200
130
70
Concentration
(M)
1.02
2.04
2.98
3.91
5.01
5.95
Measured pH
6.33
6.70
6.80
6.88
6.99
7.03
Oflo
0.0020g
H2O
1020 microL
0.05M HCl
30 microL
0.05M NaOH**
0 microL
pH
6.78
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6.1.3 Cleaning procedures
The samples are very sensible to contamination, particularly in the small concentration range stu-
died in this thesis. It is therefore of great importance that the NMR-tubes are free from dust and
other contaminating particles.
The NMR-tubes were first filled with a deconex solution and left for several hours. They were
then rinsed three times with 5 mM EDTA and finally 10 to 15 times with deionised water.
Disposable equipment was washed three times with deionised water.
6.2 Setup for NMR experiments
Three main techniques have been used in this thesis:
1) 1D 1H NMR for assigning both GGCC and Ofloxacin and investigating the dynamics in the
methylpiperazine ring.
2) 2D NOESY for assisting the assignment of GGCC.
3) Diffusion measurements to extract information on both stacking conditions in Ofloxacin and
the affinity between GGCC and Ofloxacin.
The experiments were conducted on a Bruker DRX 600 MHz instrument. Processing of the data
was performed on a Silicon Graphics INDY workstation using Bruker XWIN-NMR software
suite v. 2.6. The spectra were analysed mainly on the same equipment.
For an explanation of the NMR parameters see Appendix C.
6.2.1 Calibration of the temperature
The temperature in the probe-head is controlled by a temperature-control unit. This unit does not
present actual temperatures and thus has to be calibrated. The temperatures are chosen by set-
ting the te parameter followed by the teset command. Temperatures given in this thesis are the tem-
perature set to the temperature control unit unless otherwise stated. Most experiments in this the-
sis are performed at 298K, except the dynamics experiments.
Table 6.6 Some actual examples of reading temperatures on the spectrometer
This render the formula:
Tactual = (1.1312 ± 0.0038) * (Treading-(38.2 ± 1.1))                     6 - 1 
Reading (K)
270.0
275.0
280.0
285.0
290.0
295.0
300.0
Actual (K)
267.4
273.0
278.5
284.1
289.8
295.5
301.3
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6.2.2 Calibration of the pulse
The 90° pulse flip angle was used for maximum signal intensity in most of the experiments in this
thesis. The pulse angle is determined by two parameters: pl1 and p1. The pulse strength, pl1, is set
on 0.00 dB in all experiments. It is given as attenuation values, meaning that greater pl1 values
gives a weaker pulse.
The duration of the pulse, p1, was calibrated using the 360° method before each session of expe-
riments[26]p62.
6.2.3 Adjusting the receiver gain
The receiver gain (rg) is set automatically in most experiments except in diffusion measurements
where the rga command  (set receiver gain automatically) cannot be used. The rg is then set in a
1D experiment and the FID controlled during the first scans in the diffusion experiment to check
the rg value. The intensity of the FID should be just below ± 50.000 on the absolute scale. The
rg value was adjusted manually whenever necessary.
6.2.4 1D 1H NMR
Adjustments of p1, o1p and sw were carried out through the simple 1D pulse program zg. 1D 1H
NMR spectra were obtained for pure Oflo and pure GGCC and the Oflo/GGCC titration sam-
ples. All samples contained water as solvent and 10% deuterium to secure a lock signal.
Table 6.7 Adjustable parameters in 1D NMR experiments
* changed to 13.5 microseconds from sample number 3 
** changed to 4.752 ppm from sample number 3 
*** changed arbitrary, see table 6.8
**** changed to 25.70 microseconds from sample number 3
Pulse program
ns
p1
o1p
rg
d1
td
sw
pl18
p0
p28
d19
te
Oflo
dpfgsew5
256
9.65 microseconds
4.750 ppm
1024
6 seconds
32 k
12.977 ppm
6.00 dB
19.25 microseconds
19.25 microseconds
143 microseconds
298 K
GGCC
dpfgsew5
256
15 microseconds
4.752 ppm
1024
2 seconds
64 k
20.0276 ppm
6.02 dB
30.00 microseconds
30.00 microseconds
150 microseconds
298 K
Oflo/GGCC
dpfgsew5
1 k
15 microseconds*
4.753 ppm**
1024***
2 seconds
64 k
20.028 ppm
6.02 dB
30.00 micro-
seconds****
30.00 micro-
seconds****
150 microseconds
298 K
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Table 6.8 rg values for acquisition of 1H NMR spectra of Oflo/GGCC in mixture
* The first NMR sample tube broke and made it impossible to tell how much Oflo from stock-solution was sup-
plied. This sample is the deluted, recovered sample after the incident without measurable addition of stock-solution
Oflo. The concentrations of the Oflo samples were calculated using intensities from the Oflo/GGCC spectra.
Intensities were corrected for different rg-values as shown above.
1D 1H NMR spectra were also obtained to determine the 90° pulse, the position of the water sig-
nal, the sweep width and checking for contamination before other spectra were acquired.
1D 1H NMR experiments on Oflo were also carried out with presaturation of the water signal
since not all protons were accounted for in the w5-water suppression experiment. Spectra at 278,
288, 298, 300, 310, 315, 320, 325 and 330K were obtained.
Table 6.9 Adjustable parameters for acquisition of spectra of Oflo with presaturation of water 
* for experiments at 278, 288 and 230K the value 26.7035 ppm was used, aq changed accordingly.
A temperature change induces a drift in the chemical shift for the water signal and o1p therefore
GGCC without* stock-solution Oflo
with 10 microL stock-solution Oflo
with 20 microL stock-solution Oflo
with 30 microL stock-solution Oflo
with 40 microL stock-solution Oflo
with 50 microL stock-solution Oflo
with 60 microL stock-solution Oflo
with 70 microL stock-solution Oflo
with 80 microL stock-solution Oflo
with 90 microL stock-solution Oflo
with 100 microL stock-solution Oflo
rg-values 
1024
1024
645.1
1824.6
1625.5
1625.5
1625.5
1625.5
1625.5
1625.5
1625.5
Parameter
Pulse program
td
ns
ds
sw
aq
rg
dw
de
d1
p1
pl9
Values
zgpr
32768
8
2
11.9705 ppm*
2.2807028 seconds
90.5
69.600 microseconds
6.00 microseconds
2 seconds
14.70 microseconds
40 dB
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moved from 4.745 ppm at 278K to 4.766 ppm at 230K.
All spectra were processed with si equal to td for maximum resolution. The FID was multiplied
with an exponential weightening function, em, and line broadening was set to secure good signal
to noise ratio, typically 0.50 - 2.00 Hz.
6.2.5 2D NOESY
The NOESY technique  was used to assist the assignment of GGCC and to obtain information
on any cross-linking between GGCC and Oflo. Two NOESY spectra were obtained, one of pure
GGCC and one of GGCC/Oflo after the last titration.
To secure equal conditions, no aquisition- or processing parametres were changed between the
two acquisitions.
Table 6.10 Adjustable parameters of the NOESY experiments
Water suppression was conducted using the w5 pulse sequence and linear prediction applied to
enhance signal to noise ratio.
Acquisition parameter
td
sw
pulse program
o1p
rg
d1
p1
pl18
p0
p28
d19
d8
Processing parameter
si
WDW
SSB
lb
ME_mod
LPBIN
MC2
Values
noesydpfgsew5
4.754 ppm
1448.2
1.3 sec
14.00 micro sec
6.02 dB
28.76 micro sec
28.76 micro sec
150.00 micro sec
250 milli sec
F2
2 k
20.0276 ppm
F1
1 k
20.0276 ppm
2 k
QSINE
2
2 Hz
no
0
2 k
QSINE
2
2 Hz
LPfc
2048
States-TPPI
55
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6.2.6 Diffusion measurements
Three different diffusion measurements were performed:
1) The self diffusion constants for Ofloxacin and GGCC.
2) Diffusion measurements on different concentrations of Ofloxacin to check for stacking.
3) Measurements on a GGCC sample with different concentrations of Ofloxacin to measure the
association between Ofloxacin and GGCC.
6.2.6.1 Self diffusion constants
The self-diffusion constant for Ofloxacin was calculated from the stacking experiment.
The self-diffusion constant for GGCC was determined using four different peaks at 7.12, 7.81,
8.18 and 8.28 ppm to rule out mistakes.
The diffusion measurements for GGCC cannot be based on the same pulse sequence as for Oflo
(see theory chapter 5.4). Because of the different pulse sequences, the parameters are also set diffe-
rently.
Table 6.11 Acquisition parameters for the determination of the self-diffusion constant for GGCC
Parameter
Pulse program
td
ns
ds
sw
rg
dw
de
d1
d16 (Tau)
p16 (Little delta)
d20 (Big delta)
d21
p1
p28
pl18
Values
ledbp19gs2s.nf
16384
64
16
22.0410 ppm
32
37.800 micro sec
6.00 micro sec
6.00 sec
0.005 sec
2300.00 micro sec
0.065 sec
0.005 sec
15.0 micro sec
29.93 micro sec
6.02 dB
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6.2.6.2 Stacking measurements for Ofloxacin
The stacking measurements are based on the self-diffusion constant for Ofloxacin at different
concentrations. Stacking leads to greater clusters of molecules and therefore a smaller diffusion
constant.
The diffusion constant was measured at six different concentrations of Ofloxacin; 1.02, 2.04, 2.98,
3.91, 5.01 and 5.95 M. The acquisition parameters used in all the experiments were not changed
to secure equal conditions for comparison of results.
Table 6.12 Adjustable parameters in diffusion measurements of Oflo to investigate stacking
* changed to 12.977 ppm from experiment number 4, dw is changed accordingly
Big delta is not a directly adjustable parameter in the pulse program and is calculated in a spin echo
experiment using the equation:
In this experiment big delta was calculated to be 19.76 milliseconds.
Parameter
Pulse program
td
sw
ns
ds
rg
dw
de
d1
d16 
p16 (Little delta)
d19
p0
p1
p28
pl18
Value
segsw5
8192
5.0069 ppm*
22
4
30
166.400 microseconds
6 microseconds
6 seconds
0.012 seconds
4 milliseconds
0.0002 seconds
19.30 microseconds
9.65 microseconds
19.30 microseconds
6.02 dB
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' = p16 + d16 + 5.949 * p28 + 18 * d19 + 46 Ps   6 – 2 
6.2.6.3 Measurements of the affinity between Ofloxacin and GGCC
The affinity measurements were carried out exactly as the diffusion measurements. Diffusion
measurements were performed on both Oflo and GGCC for comparison of results.
Measurements with focus on GGCC used the same parameters as in table 6.11 and measurements
with focus on Oflo used the same parameters as in table 6.12, adjusting p1, o1p and rg to fit the
experiments. Adjustments of these parameters do not affect the experiment.
6.2.7 Calculating the diffusion constants
After acquisition the t1/t2 part of XWin NMR was used to calculate the constants. After phasing
the spectra, the t1/t2 program is opened with the t1/t2 command. The program reads the spec-
tra applying the rspc command and the marker is set on the peak in question. The program, using
the ppt1 command, then reads all intensities of the peak in the second dimension. For some reason
(a logical mistake in the program) the t1/t2 program then needs to be opened again. The pd com-
mand now gives a curve with all the intensities, normalizing the first peak to 1. The simfit com-
mand present a simulated fitness curve on the plot and the diffusion constant reads out directly
from the program.
Noise and ringing left the first spectrum in the diffusion measurement series impossible to use at
the peak in question when applying a stimulated spin echo pulse sequence. This unabled the t1/t2
program to calculate the diffusion constant, but  the peak from the water signal made it possible
to define the gradient strength and the intensities of the peak in all the spectra in the series were
read out and the diffusion constant calculated manually as described in chapter 5.5.
58
Experimental
59
7.1 Ofloxacin (Oflo)
7.1.1 Assignment of 1H NMR spectrum of Oflo
Oflo contains two aromatic protons, in positions 5 and 8, expected to have chemical shifts
somewhere between 6 and 9 ppm. The two methyl groups positioned at C3 and N4´ are expec-
ted to give signals in the region 0.5 - 3 ppm. The protons sited on the methylpiperazin ring and
on C2 and C3, are expected to have chemical shifts somewhere between the methyl groups and
the water signal.
Due to the fluorine in position 9 the signal from H8 is splitted in a dublett. The other signal in
the aromatic region must therefore result from H5. The two protons H2a and H2b are not che-
mically identical and will split each other. It is not possible to predict which of the two signals is
from which proton from the available data. The assignment of H3 on the other hand is now obvi-
ous although difficult to observe due to the water signal. The signal from H3 was easier to obser-
ve in a spectrum obtained using D2O as solvent (see Appendix A). Because of the suppressed  water
signal the coupling constant in the H3 signal is not very reliable, but from the structure one can
see that the only methyl group splitted from one proton is C3-methyl. J-coupling similar to that
measured for C3-methyl is expected. The two methyl signals are easily distinguished; the N4´-met-
hyl is situated on a nitrogen atom giving a downfield singlet and the C3-methyl protons couple
7. Results
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
5
8
Water
3
2a/2b
3´/5´
2´/6´
N4´-methyl
C3-methyl
Figure 7.1 1H NMR spectrum of 5.01mM Ofloxacin in water (pH 6.99) and D2O (10%). The spectrum was
aquired at 294K (actual temperature), and the water signal was suppressed by presaturation.
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with H3, hence the most upfield signal with the splitting must be the C3-methyl-group. The broad
bump at ~3,3 ppm are the 2´/6´ protons. The methylpiperazine ring has a hindered motion and
the signal from 2´/6´ is at coalescence at this temperature. A further investigation of this pheno-
menon is given in the following session.
Table 7.1 Chemical shift-values for Oflo
7.1.2 Dynamics of the methylpiperazine ring
As can be seen from figure 7.1, 294 K is the coalescence temperature for the motion of the met-
hylpiperazine ring. The development of the top from the 2´/6´ protons are shown in figure 7.2.
The rate constants for the dynamics can be calculated using the following equations:
Slow exchange (i.e. distinct resonances observed for each pair of protons)
Coalescence (i.e. exhanging resonances just merge into a single peak)
Fast exchange (i.e. one averaged resonance observed)
where
w0 is the width at half height for the peak at the low temperature limit, wf the half height for the
peak at high temperature limit and w is the width at half height for the peak in question.
(delta v) is the chemical shift difference between the reconances in the low temperature limit.
The upper and lower temperature limits was found and w0, wf, w and (delta v) measured.
Proton (s)
C3-methyl
N4´-methyl
2´/6´
3´/5´
2a2
2b2
31
8
5
ppm
1.48
2.91
coalecence
3.55
4.52
4.39
4.7
7.52
8.39
multiplicity
d
s
-
t
dd
dd
m
d
s
J (Hz)
6.9 
-
-
4.7
11.4/1.7
11.4/2.4
-
12.7
-
1 From D2O spectrum without water suppression (spectrum appended)
2 It is not possible to separate the two tops from the data available
k = S(w-w0)        7 – 1  
k = S(GQ)(2)-1/2       7 – 2   
k = S(GQ)2(w-wf)-1(2)-1/2      7 – 3  
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Table 7.2 Summary of parameters obtained from the temperature series of the methylpiperazine
protons
*k cannot be calculated for the upper and lower temperature limits.
Both Eyring and Arrhenius plots were prepared and thermodynamic parameters for the rotation
calculated. The plots are shown in figure 7.3.
Table 7.3 Calculated thermodynamic parameters for the rotation of the methylpiperazine ring
T (K)
271
283
294
308
313
319
324
330
w (Hz)
33.3 (w0)
58.2
--
46.9
31.4
23.5
18.0
16.9 (wf)
Peak distanse (Hz)
156.5 (delta v)
155.0
--
--
--
--
--
--
Calculated k (Hz)
--*
78.3
347.5
1810.3
3758.2
8264.5
49436.8
--*
2.602.803.003.203.403.603.804.00
330.1K
324.4K
318.8K
313.1K
307.5K
293.9K
271.3K
282.6K
Figure 7.2 The developement of the 2´/6´ signal with changing temperature. Sample and conditions are the same
as for spectrum in figure 7.1. The spectra are placed on top of each other and due to temperature change the che-
mical shifts drift.
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Delta H
91 kJ/mol
Delta S
120 J/Kmol
Delta G
58 kJ/mol
Ea
107 kJ/mol
Table 7.4 Data for Eyring and Arrhenius plots
7.1.3 Stacking measurements 
Investigations of the stacking conditions in Oflo were performed by measuring the self-diffusion
constant in a series of concentrations using the spin echo sequence. The constants were calcula-
ted directly in the t1/t2 part of the XWinNMR program.
Table 7.5 Self-diffusion constants for Oflo at different consentrations
The uncertainty is indicated at the first constant in each case. 
* The diffusion constant at 8.4 ppm was not measured for all concentrations since the width of the spectra was
maladjusted for the first three concentrations.
The diffusion constant at 8.4 ppm is included as a reference to the diffusion constant for GGCC
which was measured at peaks in the same region. The samples were not adjusted for pH, but pH
is well in between the pKa-values (6.05 and 8.22 respectively) and is thus not expected to have con-
siderable effect on the diffusion constant. The concentration might also affect diffusion constants.
Diffusion constants plotted against pH and concentration are given in figure 7.4.
y = -11156x + 38,148
R2 = 0,9983
-2
-1
0
1
2
3
4
1/T
Ln
(k/
T)
Figure 7.3 Eyring plot and Arrhenius plot of the dynamic of methylpiperazine.
y = -11456x + 44,852
R2 = 0,9984
0
1
2
3
4
5
6
7
8
9
10
0,0031 0,0032 0,0033 0,0034 0,0035 0,0036
1/T
Ln
 k
T (K)
283
294
308
313
319
Ln [k/T]
-1.283
0.171
1.773
2.486
3.256
1/T (K-1)
0.00354
0.00341
0.00325
0.00319
0.00314
Ln k
4.361
5.851
7.502
8.232
9.020
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Concentration
1.02 ± 0.09 mM
2.04
2.98
3.91
5.01
5.95
pH
6.33
6.70
6.80
6.88
6.99
7.03
D2.9 (*10-10m2s-1)
4.44 ± 0.06
4.41
4.38
4.33
4.38
4.23
D3.5 (*10-10m2s-1)
4.38 ± 0.06
4.36
4.33
4.34
4.29
4.21
D8.4 (*10-10m2s-1)
--*
--*
--*
4.31 ± 0.06
4.36
4.27
Without concern of variations from sample concentration and pH, Oflo has a mean diffusion
constant of D = 4.36 ± 0.06 * 10-10 m2s-1 (taken from the peak at 2.9 ppm only)
Results
64
4,10E-10
4,15E-10
4,20E-10
4,25E-10
4,30E-10
4,35E-10
4,40E-10
4,45E-10
4,50E-10
4,55E-10
6 6,5 7 7,5
pH
D
iff
us
io
n 
co
ns
ta
nt
 (m
2/s
)
2.9 ppm
3.5 ppm
8.4 ppm
4,10E-10
4,15E-10
4,20E-10
4,25E-10
4,30E-10
4,35E-10
4,40E-10
4,45E-10
4,50E-10
4,55E-10
0,00 2,00 4,00 6,00 8,00
Concentration (mM)
D
iff
us
io
n 
co
ns
ta
nt
 (m
2/s
)
2.9 ppm
3.5 ppm
8.4 ppm
Figure 7.4 Diffusion constants plotted against pH and concentrations for Oflo. The plots show all the peaks and
uncertainties in the diffusion constants are shown in each point. The uncertainty in the x-direction is not shown.
7.2 The DNA-oligomer GGCC
7.2.1 Assignment of NMR spectra of the oligomer GGCC
The GGCC oligomer is a palindromic, self-complementary sequence and has two identical strands
in the double helix, namely:
5´ - T1 A2 T3 G4 G5 C6 C7 A8 T9 A10 - 3´
The two sequences give rise to two sets of equal signals from the ten base pairs.
7.2.1.1 1H NMR spectrum of GGCC
A complete assignment of the oligomer was not conducted although most of the aromatic regi-
on of the oligomer had to be assigned by 1H NMR and NOESY to investigate the development
during the titration with Oflo. The assignment was assisted by a previous assignment by Vinje et
al.[32]. Only parts of the assignment is published, but the rest was kindly handed out by mr. Vinje.
From figure 7.7 it is obvious that the DNA is in double helix state since all five imino protons are
observable. The imino protons exchange too fast on the NMR time scale to be observed unless
they are involved in hydrogen bonds in a double helix. Signals from T1 and T9 have low intensi-
Results
1234567891011121314
Imino
Aromatic
H1´
H3´
H4´/H5´/H5´´
H2´/H2´´
CH3
Figure 7.5 1H NMR spectrum of 0.58 mM GGCC with phosphate buffer acquired at 298 K. The regions for
the different groups of protons are indicated.
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ties as the outer base pairs are expected to be less stable than the rest of the base pairs. Also,
Thymine - Adenine pairs only have two hydrogen bonds and Guanine - Cytosine has three hydro-
gen bonds. The low intensities of the Guanine signals, especially G4, are caused by paramagnetic
impurities. This was expected as purification for paramagnetic impurities was not conducted. The
C6 and T1 signals in the aromatic region are overlapping.
Table 7.6 1H chemical shifts in the aromatic and imino regions of the 1H NMR spectrum of pure
GGCC
Results
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7.007.207.407.607.808.008.208.408.60
A2
A8
A10
G4
A2H2
A8H2
G5
A10H2
C7
T1
C6
T3
T9
Figure 7.6 The 1H NMR spectrum of GGCC expanded in the aromatic region. 
Aromatic protons
T1
A2
T3
G4
G5
C6
C7
A8
T9
A10
A2H2
A8H2
A10H2
Imino protons
T1
T3
T9
G4
G5
Chemical shifts (ppm)
7.28
8.42
7.15
7.79
7.68
7.30
7.43
8.28
7.12
8.18
7.81
7.74
7.52
12.95
13.45
13.29
12.75
12.88
7.2.1.1 NOESY spectrum of pure GGCC
The NOESY spectrum is helpful in confirming the helix structure of the oligomer. A NOESY
sequential walk has been conducted in the aromatic region.
As can be seen in the NOESY spectrum some overlap of peaks in the aromatic region occures.
The sequential walk is based on reference [30].
Figure 7.8 The NOESY spectrum of 0.58mM GGCC at 298 K. Two parts of the spectrum is further inve-
stigated and expansions are given in the following figures. 
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12.012.212.412.612.813.013.213.413.613.814.0
T3
T9 T1
G4
G5
Figure 7.7 The 1H NMR spectrum of GGCC expanded in the imino region.
The NOESY sequential walk is performed in the aromatic-aromatic region. Crosspeaks between
the H6/H8 protons on the base and H1’ on the sugar are marked in the spectrum with the name
of the bases. Between each internal crosspeak there is a crosspeak between the H1’ on the sugar
and H6/H8 on the base below. These crosspeaks are not specifically marked in the spectrum. As
example; A2 and T3 are marked in the spectrum. These crosspeaks result from H8 on A2 and H1’
on the sugar to whom A2 is attached, and H6 on T3 and H1’ on the sugar to whom T3 is atta-
ched respectively. Between these two crosspeaks there is an unmarked crosspeak, this is the H1’
on the sugar to whom A2 is attached and H6 on T3.
Only two crosspeaks are missing in the sequential walk; crosspeaks between T1 and A2 and bet-
ween T9 and A10. This is expected as the outer base pairs are less stable than the rest of the base
pairs.
Another expansion is shown in figure 7.10. In this region the crosspeaks between H2’ and H2’’
on the sugar ring and the H6/H8 on the bases are observable. This is also a sequential walk, alt-
hough more complicated. The bases each result in four crosspeaks; two from H6/H8 to H2’ and
H2’’ on the sugar to whom they are attached and two from H6/H8 to the H2’ and H2’’ on the
sugar on the previous base. T1 without a sugar attached in 5’ position will only give rise to two
crosspeaks. Although not illustrated by lines, all the crosspeaks expected are present in the 
Figure 7.9 NOESY sequential walk in the expanded aromatic region of the NOESY spectrum of GGCC. 
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spectrum indicating a completely intact double helix. The ppm values for the crosspeaks are sum-
marised in table 7.13.
Results
Figure 7.10 An expansion of the aromatic-anomeric region of the NOESY spectrum of GGCC.
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7.2.2 Measurements of the self diffusion constant of GGCC
The calculations in XWinNMR do not take into account the effect of tau when bipolar pulses are
used. For that reason the intensities from all the scans had to be read out and the diffusion con-
stant calculated manually. First the normalised intensities were plotted against the gradient
strength to rule out any abnormal points (so-called “Simfit” plot) and then the natural logarithms to
the normalised intensities were plotted against x (see equation 5 - 11). The resulting coefficient will
give the diffusion constant.
A 0.58 mM sample of GGCC was used for self-diffusion constant measurements. The diffusion
constant of GGCC is not expected to depend on the concentration. No experiments were con-
ducted to confirm this assumption. The Simfit plot and regression plot for the peak at 7.81 ppm
are shown in figure 7.11. Intensities and some of the other simfit and regression plots are appen-
ded in appendix A. Four peaks were used to control the results and calculate the uncertainty.
Table 7.7 Diffusion constant of GGCC calculated at different chemical shifts
This gives a mean diffusion constant of 1.34 (± 0.07) * 10-10m2s-1
The uncertainty in all diffusion constants in GGCC are taken to be ± 0.07
7.3 Oflo and GGCC titration
7.3.1 Oflo concentration
Unfortunately, immediately after 10 microL stock-solution Oflo was imbedded in the sample of
pure GGCC, the NMR-tube was dropped on the floor and broke. The sample was reproducible,
but there were no means of telling how much of the Oflo stock-solution got into the GGCC sam-
ple. UV-measurements were tempted, but unfortunately the Oflo concentration was too small. We
decided to maintain the experiment rather than to start over , which would have set the experi-
Results
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Figure 7.11 Simfit and regression plots for diffusion measurements of GGCC for peak at 7.28 ppm
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mental time back two to three weeks. The concentration of Oflo in the GGCC sample  was cal-
culated after the experiments were ended. The N4´-methyl protons from Oflo appear in a part of
the spectrum where GGCC protons do not have any signal and the intensities from this signal
were used to calculate the concentration of Oflo. As can be seen from the spectra of the Oflo-
GGCC titration, the N4´-methyl signal divides into two distinct peaks, labeled N4´-methyl (a) and
N4´-methyl (b). The development of both these peaks taken together resulted in a good regres-
sion line giving the initial Oflo concentration.
Table 7.8 Data used to calculate the initial concentration of Oflo in the Oflo-GGCC titration
The applied volume Oflo after the accident was of course known. The initial concentrations could
therefore be calculated by first plotting the applied concentrations as a function of intensities and
doing a linear regression on the plot. The regression equation then allows the concentrations to
be adjusted to make the regression-line go through origo. This resulted in the initial concentrati-
ons summarised in table 7.8. The plots of the intensities from the N4´-methyl signals (a) and (b)
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Total volume
(microL)
450
460
470
480
490
500
510
520
530
540
550
Intensities 
N4´-methyl
37759020
61711756
120743385
184438117
241256290
298115926
311314224
405830963
453484661
502948887
542229480
Intensities
N4´-methyl (a)
23420351
33883856
60371693
113001393
172066726
213504437
213364334
288835929
320176475
353626474
378896227
Intensities 
N4´-methyl (b)
14338670
27827900
60371693
71436724
69189564
84611489
97949890
116995034
133308186
149322413
163333253
Concentration
(mM)
0.07
0.13
0.24
0.35
0.45
0.56
0.66
0.76
0.86
0.95
1.05
y = 526029411,8245x
R2 = 0,9993
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Figure 7.12 Intensities of both Oflo tops plotted against initial concentrations
and both taken together against the concentration are given in figures 7.12 and 7.13.
Two signals from N4´-methyl were not expected, this is further discussed in chapter 8.3.2
This method complicated the calculations of the uncertainty of the concentrations as the inten-
sities are read out from the XWinNMR program without any uncertainty given. The uncertainty
of ± 0.09 from the stock-solution is used.
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Figure 7.13 Intensities of the N4´-methyl (a) signal and the N4´-methyl (b) signal plotted against initial con-
centration of Oflo
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2.752.802.852.902.953.003.053.10
N4´-methyl (a)
N4´-methyl (b)
0.15
2.67
Figure 7.14 The development of the Oflo top at 2.9 ppm through the different concentrations, from 0.07 mM
(lower) to 1.05 mM (upper). Oflo:GGCC ratios at first and final spectra are shown.
The relative development of the peaks was calculated using intensities (see table 7.8) and is given
in the table below.
Table 7.9 Relative development of the two N4´-methyl signals
If the splitting of the N4´-methyl signal arises from interactions with DNA this gives the ratio
between interacting and non interacting Oflo. This is further discussed in chapter 8.3.2.
Results
Ratio Oflo:GGCC
0.15
0.27
0.52
0.77
1.03
1.29
1.56
1.83
2.11
2.39
2.67
% from total (N4´-methyl(b))
38.0
45.1
50.0
38.7
28.7
28.4
31.5
28.8
29.4
29.7
30.1
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7.3.2 Titration of GGCC with Oflo
7.3.2.1 1D spectra 
The rest of the 1D 1H NMR spectra is appended.
The development of the peaks may be seen in three different areas; the imino, the aromatic and
the 1.0 - 4.5 ppm regions of the proton spectra. The development in the three different  regions
are shown in figures 7.16 to 7.18.
The imino region:
All imino signals are behaving rather similar. With the exception of T1, which is completely lost
at ratio 0.27, all imino signals are decreasing, showing the largest decrease between ratios 0.52
and 0.77. Only signals from T3 and T9 are observable in the last spectrum (ratio 2.67). The G5
signal are lost at ratio 1.56, and the same applies to the G4 signal.
The aromatic region:
There are three things worth noticing in this region. The adenine signals are only slightly chang-
ing, showing a decrease in intensity (especially at A10) and a broadening of the peaks, but are essen-
tially the same. The Guanine peaks from G4 and G5 are broadening and decreasing, almost vanis-
hing, and already at ratio 0.52 the peaks are almost indistinguishable, with the exception of the
Results
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0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
Figure 7.15 The final 1H NMR spectrum in the titration, the ratio Oflo:GGCC is 2.67. 
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12.2012.4012.6012.8013.0013.2013.4013.6013.80
0.15
0.27
0.52
0.77
1.03
1.29
1.56
1.83
2.11
2.39
2.67
T3 T9
T1
G5
G4
Figure 7.16 The development of the imino proton region in the titration, ranging from ratio Oflo:GGCC 0.15
(lower) to 2.67 (upper). The spectra are placed on top of each other.
7.207.407.607.808.008.208.40
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2.11
2.39
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A2 A8 A10 A2H2
G4
A8H2
G5
A10H2 C7 C6
T1
T3T9
Figure 7.17 The development in the aromatic region in the titration, ranging from ratio Oflo:GGCC 0.15
(lower) to 2.67 (upper)
A2H2 signal. The only signals remaining at the end, although broadened and decreased are the
A2H2 and A10H2 signals and the T1 and T9 signals. The T3 signal disappears quickly, probably
shifting to the same ppm value as T9.
The 1.0 - 4.5 ppm region:
This region has not been completely assigned and are also more complicated as there is heavy
overlap between the peaks. The most distinct changes, however, in this region are increasing sig-
nals from the N4´-methyl and 3’/5’ protons in Oflo at 2.9 and 3.5 ppm respectively. An interest-
ing feature, although difficult to observe in figure 7.18, are the methyl signals completely separa-
ted in the final spectrum giving rise to five different peaks, although only four methyl groups are
present to give signals in this area. The intensities of the methyl signals are clearly increasing until
ratio 0.77, decreasing at ratios 1.03 and 1.29 and then increasing again. The fifth methyl signal aris-
es from the C3-methyl group in Oflo separating like the N4´-methyl signal, but not in a similar
manner.
Results
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1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.4
0.150.27
0.52
0.77
1.03
1.29
1.56
1.83
2.11
2.39
2.67
Figure 7.18 The development of the peaks in the 1.0 - 4.5 ppm region in the titration, ranging from ratio
Oflo:GGCC 0.15 (lower) to 2.67 (upper)
The relationship between the peaks has been calculated as with the N4´-methyl group
Table 7.10 The relationship between C3-methyl groups a) and b)
The results are based on calculations using
the intensities from both peaks in the dou-
blet. It was not possible to separate the two
peaks to read out intensities below a
Oflo:GGCC ratio of 1.03.
1.401.451.501.551.60
T1 T9
C3-methyl (a)
C3-methyl (b)
T3
2.67
2.39
2.11
1.83
1.56
1.29
1.03
0.77
0.52
0.27
0.15
Figure 7.19 The development of the methyl-signals from both GGCC and Oflo. The signals are labelled and
the ratio Oflo:GGCC is shown to the left. 
Ratio Oflo:GGCC
1.03
1.29
1.56
1.83
2.11
2.39
2.67
% from total (C3-methyl (b))
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Figure 7.20 Intensities of the two C3-methyl peaks
against Oflo concentration
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7.3.2.2 NOESY spectra
Unfortunately, no NOESY spectra were recorded during the titration. The only NOESY spectra
available are that of pure GGCC and the final sample in the titration series of Oflo and GGCC.
Two regions have been investigated as mentioned in chapter 7.2.3; the H6/H8 - H1’ and the
H6/H8 - H2’/H2’’ regions. Chemical shifts in both dimensions for pure GGCC and for the final
sample in the Oflo and GGCC titration are summarised in tables 7.11 and 7.12 for comparison.
Table 7.11 Chemical shifts in ppm for crosspeaks for H6/H8 and H1’ in the NOESY spectre of
both dimensions for pure GGCC and the final sample in the Oflo GGCC titration 
-- means the crosspeak are missing in the NOESY spectrum
Crosspeaks between the two pairs at both ends are missing from the NOESY spectrum of pure
GGCC, otherwise all crosspeaks are accounted for. In the Oflo GGCC mixture most crosspeaks
between the base pairs are missing with the exception of the crosspeaks between C6 and C7 and
between A8 and T9. All the internal crosspeaks between H6/H8 and H1’ in the bases and their
respective sugars are observable, with a possible exception of the crosspeak between G5H8 and
G5H1’.
Although some of the peaks are weak and broad, they are found symmetrically across the diago-
nal and thereby confirmed. Their positions are in good coherence with expected positions in the
spectra. In figures 7.17 and 7.18 low resolution are used and some of the crosspeaks may not
appear but this does not imply that they are not present.
Results
Crosspeak between
T1H6 - T1H1’
A2H8 - T1H1’
A2H8 - A2H1’
T3H6 - A2H1’
T3H6 - T3H1’
G4H8 - T3H1’
G4H8 - G4H1’
G5H8 - G4H1’
G5H8 - G5H1’
C6H6 - G5H1’
C6H6 - C6H1’
C7H6 - C6H1’
C7H6 - C7H1’
A8H8 - C7H1’
A8H8 - A8H1’
T9H6 - A8H1’
T9H6 - T9H1’
A10H8 - T9H1’
A10H8 - A10H1’
Pure GGCC Oflo and GGCC mixture
F2
7.28
--
8.43
7.16
7.16
7.79
7.79
7.68
7.68
7.30
7.30
7.44
7.44
8.29
8.29
7.12
7.12
--
8.19
F1
5.78
--
6.30
6.30
5.69
5.69
5.67
5.67
5.85
5.85
5.88
5.88
5.49
5.49
6.21
6.21
5.83
--
6.26
F2
7.30
--
8.41
--
--
--
--
--
--
--
--
--
--
8.30
8.30
7.14
7.17
--
8.20
F1
5.80
--
6.26
--
--
--
--
--
--
--
--
--
--
5.53
6.18
6.17
5.84
--
6.24
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Figure 7.22 Expansion of the H6/H8-H2’/H2’’ region of the NOESY spectrum of the Oflo-GGCC
mixture
Figure 7.21 Expansion of the H6/h8-H1’ region of the NOESY spectrum of the Oflo-GGCC mixture
Table 7.12 Chemical shifts in ppm for crosspeaks resulting from H6/H8 and H2’/H2’’ in the
NOESY spectra of both dimensions for pure GGCC and the final sample in the Oflo-GGCC
titration 
( ) indicates weak signals which are confirmed from the symmetric side of the diagonal.
As the table shows, there is a big gap of missing peaks from G4H8 and the T3 sugar ring and all
the way down to C7H6 and the C6 sugar ring. There are still crosspeaks in this region, but they
Results
Crosspeaks between
T1H6 - T1H2’
T1H6 - T1H2’’
A2H8 - T1H2’
A2H8 - T1H2’’
A2H8 - A2H2’
A2H8 - A2H2’’
T3H6 - A2H2’
T3H6 - A2H2’’
T3H6 - T3H2’
T3H6 - T3H2’’
G4H8 - T3H2’
G4H8 - T3H2’’
G4H8 - G4H2’
G4H8 - G4H2’’
G5H8 - G4H2’
G5H8 - G4H2’’
G5H8 - G5H2’
G5H8 - G5H2’’
C6H6 - G5H2’
C6H6 - G5H2’’
C6H6 - C6H2’
C6H6 - C6H2’’
C7H6 - C6H2’
C7H6 - C6H2’’
C7H6 - C7H2’
C7H6 - C7H2’’
A8H8 - C7H2’
A8H8 - C7H2’’
A8H8 - A8H2’
A8H8 - A8H2’’
T9H6 - A8H2’
T9H6 - A8H2’’
T9H6 - T9H2’
T9H6 - T9H2’’
A10H8 - T9H2’
A10H8 - T9H2’’
A10H8 - A10H2’
A10H8 - A10H2’’
Pure GGCC Oflo-GGCC mixture
F2
7.28
7.28
8.43
8.43
8.43
8.43
7.16
7.16
7.16
7.16
7.79
7.79
7.79
7.79
7.68
7.68
7.68
7.68
7.30
7.30
7.30
7.30
7.44
7.44
7.44
7.44
8.29
8.29
8.29
8.29
7.12
7.12
7.12
7.12
8.19
8.19
8.19
8.19
F1
1.74
2.16
1.75
2.16
2.84
2.96
2.84
2.96
1.98
2.37
1.98
2.37
2.63
2.71
2.61
2.71
2.53
2.66
2.53
2.67
2.06
2.43
2.06
2.43
2.03
2.35
2.03
2.35
2.62
2.81
2.62
2.81
1.87
2.23
1.87
2.23
2.62
2.43
F2
7.31
7.31
8.41
8.41
8.41
8.41
(7.11)
(7.11)
(7.11)
(7.11)
(7.46)
(7.46)
8.30
8.30
8.30
8.30
7.14
7.14
7.14
7.14
8.20
8.20
8.20
8.20
F1
1.77
2.18
1.77
2.18
2.80
2.92
(2.80)
(2.94)
(2.01)
(2.30)
(2.07)
(2.34)
2.07
2.34
2.62
2.80
2.62
2.80
1.90
2.22
1.90
2.22
2.62
2.43
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are difficult to assign. It appears that the guanine signals are broadened and overlapping. The bro-
adened signals from the Guanines are observable, but are impossible to assign to G4, G5 or both,
they are therefore not included in the table.
Table 7.13 Assignment table for pure GGCC indicating drift in the chemical shifts as Oflo is
applied
no means not observed, and nr observed, but not reliable to assign
Results
T1
Delta
A2
Delta
T3
Delta
G4
Delta
G5
Delta
C6
Delta
C7
Delta
A8
Delta
T9
Delta
A10
Delta
CH3
1.52
0.03
1.39
0.02
1.52
-0.01
H1’
5.78
0.02
6.30
-0.04
5.68
no
5.67
no
5.85
no
5.88
no
5.50
no
6.21
-0.03
5.84
0.00
6.26
-0.02
H2’
1.75
0.02
2.84
-0.04
1.98
0.03
2.63
nr
2.53
nr
2.06
no
2.03
0.04
2.61
0.01
1.87
0.03
2.62
0.00
H2’’
2.16
0.02
2.96
-0.04
2.37
-0.07
2.71
nr
2.66
nr
2.43
no
2.35
-0.01
2.81
-0.01
2.23
-0.01
2.43
0.00
H6
7.28
0.03
7.16
-0.05
7.30
no
7.44
0.02
7.12
0.02
H8
8.43
-0.02
7.79
nr
7.68
nr
8.29
0.01
8.19
0.01
NH
no
no
13.46
no
12.75
no
12.89
no
no
no
NH2b
8.11
--
8.46
--
NH2f
6.26
--
6.75
--
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7.4 Association constants
From the diffusion constants found earlier the association constants may be calculated. GGCC
and Oflo diffusion constants are as good as constant, being 1.34 * 10-10 and 4.36 * 10-10 m2s-1
respectively. Table 7.6 gives the information required to calculate association constants.
Calculation of association from diffusion constants is given in chapter 5.5.2
Table 7.14 Information for calculating the association constants using the N4´-methyl signal
The diffusion constants were calculated using the N4´-methyl signal, as this was the only Oflo
peak available at all titrations. The peaks at 3.5 ppm and 8.4 ppm were relatively weak and result-
ed in diffusion constants quite similar to pure GGCC (results not shown).
The fact that only the N4´-methyl signal at 2.9 ppm could be used to calculate diffusion constants
complicated the calculations, as this peak is splitted. The largest signal from the N4´-methyl group
was used to calculate the diffusion constant.
The association constants were calculated as follows:
- The diffusion constants of the largest N4´-methyl peak were calculated.
- Percentage interacting Oflo was calculated from the diffusion constant.
- Percentage interacting Oflo was adjusted since the peak used to calculate the diffusion constant
is not representing all Oflo in the solution.
To illustrate the calculations: In the 0.15 ratio Oflo:GGCC 57.2% Oflo is calculated to interact
with GGCC. But the peak investigated is only representing 62% of the Oflo present. The remai-
ning signal from Oflo is imbedded in the second peak, which is already assumed to interact. This
gives a corrected percentage interacting Oflo from the diffusion constant of 35.5% and a total of
73.5% Oflo interacting with GGCC.
Association constants were also calculated using the percentage development of the small N4´-
methyl signal and the C3-methyl (b) signal.
Conc. Oflo (mM)
0.07
0.13
0.24
0.35
0.45
0.56
0.67
0.77
0.86
0.95
1.05
Conc. GGCC (mM)
0.48
0.47
0.46
0.45
0.44
0.43
0.42
0.42
0.41
0.40
0.39
Diff.Oflo(*10-10m2s-1)
2.64 
2.78 
3.26 
3.22 
3.31 
3.38 
3.53 
3.42 
3.41 
3.44 
3.51 
% interacting Oflo
57.2 
52.4 
36.8 
38.1 
35.1 
32.7 
27.8 
31.5 
32.0 
30.8 
28.6 
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Table 7.15 Association constants calculated using the development of the N4´-methyl signal
Table 7.16 Association constants calculated using the development of the C3-methyl signal
The N4´-methyl signal indicates at least two different interacting modes, one that causes the dif-
ference in chemical shift and others measured from the diffusion constant. This gives the total
percentage interacting Oflo.
Table 7.17 Total percentage interacting Oflo calculated from the N4´-methyl signal
The percentage Oflo interacting and the Ka values can be presented as plots against the
Oflo:GGCC ratio as illustrated in the following figures.
Ratio
Oflo:GGCC
0.15
0.27
0.52
0.77
1.03
1.29
1.56
1.83
2.11
2.39
2.67
% from 
N4´-methyl (a)
35.5
28.8
18.4
23.4
25.0
23.4
19.0
22.4
22.6
21.7
20.0
Ka from 
N4´-methyl (a)
1.21 * 1003
9.35 * 1002
5.42 * 1002
8.30 * 1002
1.02 * 1003
1.02 * 1003
7.96 * 1002
1.16 * 1003
1.35 * 1003
1.43 * 1003
1.39 * 1003
% from 
N4´-methyl (b)
38.0
45.1
50.0
38.7
28.7
28.4
31.5
28.8
29.4
29.7
30.1
Ka from 
N4´-methyl (b)
1.35 * 1003
2.00 * 1003
2.94 * 1003
2.01 * 1003
1.29 * 1003
1.46 * 1003
2.17 * 1003
2.01 * 1003
2.65 * 1003
3.58 * 1003
5.82 * 1003
Ratio Oflo:GGCC
1.03
1.29
1.56
1.83
2.11
2.39
2.67
% from C3-methyl (b)
47.4
45.7
45.3
43.7
43.2
42.5
42.2
Ka from C3-methyl (b)
3.98 * 1003
4.83 * 1003
6.84 * 1003
8.83 * 1003
1.98 * 1004
1.97 * 1005
1.37 * 1004
Ratio Oflo:GGCC
0.15
0.27
0.52
0.77
1.03
1.29
1.56
1.83
2.11
2.39
2.67
Total percentage Oflo interacting
73.5
73.9
68.4
62.1
53.7
51.8
50.5
51.2
52.0
51.4
50.1
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Figure 7.23 Percentage interacting Oflo and Ka plotted against the Oflo:GGCC ratio as calculated using the N4´-
methyl (a) signal in Oflo
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Figure 7.24 Percentage interacting Oflo and Ka plotted against the Oflo:GGCC ratio as calculated using the N4´-
methyl (b) signal in Oflo
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Figure 7.25 Percentage interacting Oflo and Ka plotted against the Oflo:GGCC ratio as calculated using the sig-
nal from the C3-methyl group in Oflo
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8.1 Ofloxacin (Oflo)
8.1.1 Assignment of 1H NMR spectrum of Oflo
The assignment of the NMR spectrum of Oflo is relatively straight forward in most regions, but
the 2´/6´ and 3´/5´ protons are complicated to separate. No spectra were recorded enabling the
separation of the two groups. Mucci et al.[11] previously published an article investigating the
structural properties of Oflo using different NMR techniques. They reported the 3´/5´ protons
to give signals at 2.54 ppm and two sets of signals resulting from 2´/6´ protons at 3.39 and 3.44
ppm (spectrum obtained at 300 and 340K using DMSO-d6 as solvent, pH not indicated). They
proposed that the 2´/6´ protons are closer to the aromatic ring system and hence had a deshiel-
ding effect resulting in a downfield signal compared to the 3´/5´ protons. This reasoning would
lead to the conclusion that the 2´/6´ protons results in the signal at 3.55 ppm in figure 7.1.
However, it is not probable that 3´/5´ is the signal at coalescence, since the reason for split in the
signal must be either hindering of ring rotation or ring inversion. The difference in chemical envi-
ronment leading to splitting is likely to occur at 2´/6´, as these protons are positioned near the
sites where the change is likely to occur. Mucci et al. also reported splitting of the 2´/6´ signal at
300K and there is obvious coalescence at ~3.3 ppm in figure 7.1. From this it can be concluded
that the suggested assignment of the 1H NMR spectrum of Oflo is correct.
In addition Oflo contains exchangeable protons at the carboxyl group and at N4´. These protons
are not observable in the proton specrum as they exchange too fast on the NMR time scale.
It is not possible to separate the H2a and H2b protons, but their vicinal coupling to H3 give infor-
mation about the conformation of the benzoxacine ring. The C3-methyl group can either be posi-
tioned in a pseudo equatorial or a pseudo axial manner. The two possible conformations will give
approximately the dihedral angles given below.
Table 8.1 Expected coupling constants at different possible dihedral angles between H2a/H2b
and H3 
p-e means pseudo equatorial and p-a pseudo axial, the proton positioned upwards is labelled H2a.
All angles are approximations as the conformation never will be completely locked.
The coupling constants are very low (2.4 and 1.7 Hz), the conclusion must therefore be that the
C3-methyl group are positioned in a pseudo axial manner, as angles near 180 degrees result in hig-
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C3 conformation
C3 p-e
C3 p-a
H2a - H3
~180o
~60o
Expected J3
~9 - 16 Hz
~1 - 5 Hz
H2b - H3
~60o
~60o
Expected J3
~ 1 - 5 Hz
~ 1 - 5 Hz
her coupling constants according to the Karplus equations. Mucci et al. found similar low coup-
ling constants but arrived at the opposite conclusion. They stated that the low coupling constants
are typical for an axial-equatorial/equatorial-equatorial arrangement and argued that all the spec-
troscopic data reported agreed with the assignment of a pseudo equatorial arrangement of the
C3-methyl group. It is unclear why they arrive at this conclusion as they do not mention Karplus
or even discuss the dihedral angles further.
8.1.2 Dynamics of the methylpiperazine ring
There is obvious coalescence at ~3.3 ppm in figure 7.1. The development of this signal over a
temperature range can be seen in figure 7.2.
Ciprofloxacin (Cipro) has been investigated by T. Skauge [3]. The structure of Cipro resembles
that of Oflo, but a piperazine ring replaces the methylpiperazine, a cyclopropyl as R1 and a hydro-
gen attached to the carbon postitoned at X8 replaces the benzoxacine group using the nomenc-
lature in figure 3.1 a). The 1H NMR spectrum of Cipro exhibits two identical signals from the
3´/5´ and 2´/6´ protons with no coalescence neither at elevated nor decreased temperatures, lea-
ding to the conclusion that the properties of O1 and/or the methyl group on piperazine are vital
(some of this information arise from personal communication with Skauge, and not the referenced thesis).
The distance between the two signals from the 2´/6´ protons at 271 K is almost the same as at
283 K and it is reasonable to assume that the minimum temperature is found. At high tempera-
tures equal signals from the 2´/6´ and 3´/5´ protons are expected, as seen in Cipro. This is not
achieved at 330 K, the highest temperature obtained, indicating that the high temperature limit is
not found. Acquirement of spectra at higher temperatures was attempted, but failed due to loss
of lock signal and long periods of waiting for the instrument to heat up. The high temperature
limit is vital in calculations of the rate constants and thus, these rate constants must be conside-
red uncertain. The results are, however, close enough to be advisory, as calculations of dynamics
of this kind contain a high degree of uncertainty anyway. More scans are required to achieve accu-
rate results. The 2´/6´ and 3´/5´ protons are expected to couple, so the equation used to calcula-
te kc is strictly not valid as it only applies to systems not coupled to each other. Still it is supposed
to give a relatively good approximation.
The coalescence may actually arise from either hindering of ring rotation, hindering of ring inver-
sion or slow ring inversion or perhaps a combination of these.
Although the delta H, delta S, delta G and Ea given are highly uncertain, they might tell somet-
hing about the system. Large, positive delta S values are consistent with less ordered transition sta-
tes, like ligand dissociation or bond breaking. Delta S is positive and relatively high, indicating that
the coalescence is due to bonding. Hydrogen bonding could be expected as both oxygen and flu-
orine are electronegative hydrogen binders.
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Delta G for ring inversion of N-methylpiperazine is reported to be 52 kJ/mol in gaseous condi-
tions not expected to vary much in solution[33]. The coherence temperature was ~250K in the
reference, but a lower field (499.92MHz) was used, and the higher the observing frequency, the
higher the coalescence temperature. Oflo has a boat-chair inversion when inversion is hindered in
the C2´/C6´ and the inversion investigated is a chair-chair inversion. Boat-chair inversion is expec-
ted to be less favourable giving higher delta H and delta G. This is in coherence with the results
in this thesis. Thus delta G for hindering of rotation is not known and hindering of rotation can
therefore not be excluded on this ground. On the other hand, delta H is reported to be 51.9
kJ/mol, almost half of the delta H found here. This may be consistent with a boat-chair inversi-
on.
Considering that the boat-chair inversion is less probable than a chair-chair inversion, boat-chair
inversion is only likely if the 2´/6´ hydrogens are directly involved in the hydrogen bonds expec-
ted in fluorine and oxygen. This is not expected as the 2´ and 6´ protons are attached to carbons.
Also, if one considers the scalar couplings to the 3´/5´ peak there seems to be equal couplings
above coalescence and two different couplings after coalescence. This is consistent with the 2´ and
the 6´ protons having different chemical environments below coalescence, indicating hindering of
rotation.
From this it seems that the coalescence arises from a hindering of the rotation of the methylpi-
perazine ring, but no certain conclusion can be made without further investigations.
A 1H NMR spectrum of Oflo with pH 4.92 was also acquired (see appendix A). This spectrum was
acquired at 293.9K (actual temperature), but it seems clearly below coalescence. Integration of the
peaks shows that the quartet at 3.3 ppm contains two protons and the whole group of peaks rang-
ing from 3.55 to 3.70 ppm contains six protons.
The splitting of the peaks in this spectrum can be explained as follows:
The quartet at 3.30 ppm arises from 3´/5´ protons. There is fast inversion in C3´ and C5´ and the
two 3´/5´ protons are identical. There is no fast inversion in C2´ and C6´ making the 2´/6´ dif-
ferent. The 3´/5´ protons are therefore splitted from the two different 2´/6´protons and from the
proton now situated at N4´ leading to a quartet. There are in fact two quartets, but the other is
more difficult to observe. The 2´/6´ protons have a geminal coupling and are therefore splitted
in a dublet. The 3´/5´ protons split this doublet once more in a doublet. The easiest of these two
dublets to observe is the one most downfield.
This indicates two things: The assignment of the 2´/6´proton and 3´/5´ proton signals is not cor-
rect and the 3´/5´ proton signals are splitted as a result of slow inversion. No findings in the 6.99
pH spectra support this. The splitting pattern in the spectra acquired with pH 6.99 is better explai-
ned if the triplet arises from 3´/5´ protons splitted from the different 2´/6´ protons. Clearly fur-
ther investigations are needed. 2D spectra acquired at lowered temperatures can reveal whether
the two peaks at 3.00 ppm and 3.30 ppm couple to one or two carbons. If the peaks couple to
only one carbon the coalescence must arise from hindering of rotation and if they couple to two
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carbons the coalescence must arise from inversion.
8.1.3 Stacking measurements
Two or more Oflo molecules stacking together are expected to move much slower in the soluti-
on than one molecule alone resulting in a considerable decrease in the diffusion constant.The dif-
fusion constants in table 7.4 lead to the conclusion that Oflo is not stacking in the concentration
range 1 - 6 mM, i.e. there is no change in the stacking conditions. Conclusions cannot be drawn
on whether stacking occurs at lower concentrations. Unfortunately no measurements at lower
concentrations were performed. This should be conducted to confirm the results in this thesis,
especially since the self-diffusion constant of Oflo is used to calculate the association constants.
Lecomte et al.[34] investigated Pefloxacin, a fluoroquinolone with structure similar to Oflo, but
the benzoxacine ring is replaced by an ethyl-group as R1 using the nomenclature in figure 3.1 a).
They concluded that Pefloxacin is monomeric at 10-4 mol L-1 (pH 7.4) and the stacking was high-
ly dependent on pH. From figure 7.4 it appears that the diffusion constant is lowered above pH
7, which could be explained by the high dependency on pH. Diffusion measurements at different
pH is out of the scope of this thesis and since only one of the samples used has a pH higher than
7 it is impossible to investigate this aspect. Experiments focusing on stacking conditions at diffe-
rent pH should therefore be performed at a later stage.
From figure 7.4 it appears that the diffusion constant is dependent on concentration in the 1 - 6
mM  range. No conclusions can be drawn on whether this applies to the concentration levels used
to titrate GGCC. The dependency is small however, considering the uncertainty is calculated to
be ± 0.06 m2/s. The diffusion constants calculated in this thesis are regarded independent of con-
centration within the limits of the titration. Oflo is also regarded as monomeric in the stacking
measurements. No association constants could be calculated without these assumptions.
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8.2 The DNA-oligomer GGCC
8.2.1 Assignment of the NMR spectra of GGCC
This assignment is based on a previous assignment performed by Vinje et al. and parts of it have
been published[32]. The coherence between the NOESY spectra obtained in this thesis and in the
reference is substatial, leading to the conclusion that the GGCC oligomer is in fact in the duplex
state and has a normal B-DNA geometry. The appearence of imino peaks in the 1D spectrum
and imino crosspeaks in the NOESY spectrum supports the assumption of a double helix state.
The magnitude of the NOESY crosspeaks indicates B-DNA geometry.
Crosspeaks between A10 and T9 and between T1 and A2 are missing in the NOESY spectrum
(figure 7.9). This comes as no surprise as they are the base pairs positioned at the ends of the oli-
gomer. adenine-thymine pairs at the ends often give open ends as they only exhibit two hydrogen
bonds.
It is apparent from the aromatic region that paramagnetic impurities are present (figure 7.6).
Paramagnetic impurities especially bind to GC base pairs and the G4 and G5 signals are clearly
broadened and damped. This could be expected as purification of paramagnetic impurities was
not conducted. It was however at the time not considered to have any impact on the final results.
The oligomer is rather large compared to any impurities. The diffusion constant is therefore not
expected to differ and diffusion constants can be measured using any single resonance signal from
the spectrum rendering the G or C signals disposable for diffusion measurements. The paramag-
netic impurities may have had an impact on the interaction between Oflo and GGCC. This is fur-
ther discussed in chapter 8.5
The pH of the sample was not measured. A phosphate buffer was used, but no measurements
were performed to secure that enough buffer was applied. The final pH of the sample at end of
the titration was 6.54. Given that the pH of the stock-solution Oflo was 6.99 and a total of 110
microL of this sample was impeded in the GGCC sample (450 microL initial volum), this predicts
a starting pH somewhere above 6, which should be sufficient. Thus, pH is not expected to affect
the results.
8.2.2 Measurements of the self-diffusion constant of GGCC
The diffusion part of the XWinNMR program does not take into account tau when bipolar puls-
es are used, complicating the calculations and they must therefore be conducted manually. The cal-
culations are performed using the same data as XWinNMR, the uncertainty is thus not affected.
The sample with the lowest concentration of GGCC results in a poor Simfit plot (see Appendix A).
Even so, the diffusion constant is only 0.023 * 10-10 higher than the diffusion constant obtained
for pure GGCC. The uncertainty of the self-diffusion constants will be high in this concentrati-
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on range as the signals are weak. Acquiring more scans could have improved this. All measure-
ments were acquired using the same number of scans. Not changing the number of scans made
the experimental time shorter, but it also gave information on what concentration range the dif-
fusion constants may be acquired at approximately without too high uncertainty. The borderline
of certain results appears to be precisely at the concentration levels used in this thesis. This should
apply to all diffusion constant measurements.
From the small deviations in the diffusion constant of GGCC in the titration series it is clear that
the diffusion constant of GGCC can be taken as constant. This was expected, as diffusion con-
stants are more influenced by molecular size and geometry than structure. Without this assump-
tion it would not be possible to calculate the association constants from the diffusion constants.
The diffusion constant calculated is in coherence with previously calculated self-diffusion con-
stants for DNA[30, 35] and supports the suggested double helix conformation of the oligomer.
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8.3 Oflo and GGCC titration
8.3.1 Oflo concentration
Calculations of initial concentration of Oflo in the GGCC sample increase the uncertainty.
Precise calculations of how much it should be increased are impossible, the uncertainty of ± 0.09
mM from the stock-solution is therefore kept. The Oflo sample of concentration 0.07 mM falls
within the uncertainty of 0.09 mM and is considered not dependable.
The point at (0.66 , 311314224) is removed from all the plots, as this point was clearly deviating
from the regression line.
The splitting of the N4´-methyl signal from Oflo was not expected. There are at least two pos-
sible explanations; it could either result from Oflo interacting with GGCC or it could result from
an additional proton at N4´. The N4´ nitrogen is protonated at lowered pH. This proton may not
appear in the 1H spectrum but is expected to split the methyl signal. The pKa1 value for Oflo is
6.02. The N4´-methyl (b) signal is strong and increasing. Since pH of the sample increases as Oflo
stock-solution is added, the protonation of N4´ should decrease. Splitting of the N4´-methyl sig-
nal resulting from protonation of N4´ is expected to give two signals with equal intensity while
the two signals observed clearly has different intensities and even different development of the
intensities as Oflo is imbedded in the GGCC solution. A spectrum of Oflo acquired at lowered
pH confirms this (see appendix A). Even at pH 4.92 the N4´-methyl signal is not splitted, i.e. the
splitting is unobservable. One can therefore conclude that the two signals must arise from inter-
actions between Oflo and GGCC.
Given the conclusion that the N4´-methyl signal is splitted from interactions between Oflo and
GGCC, the development of the two peaks are worth investigating. From the plots in figure 7.13
it can be seen that the two signals develop differently. The N4´-methyl (a) signal is growing slow-
ly in the first three spectra and then more rapidly. This growth from the fourth spectrum appears
to slow down in the four last spectra. The N4´-methyl (b) signal behave quite differently. In the
first three spectra the intensities increase rapidly, then flattens out and then in the last five spectra
increase again. From investigations of the 1H NMR spectra one conclude that intercalation of
Oflo in to GGCC is taking place at ratios Oflo:GGCC higher than 1 (see chapter 8.3.2). The N4´-
methyl signal is distinctly splitted already at Oflo:GGCC ratio 0.15, so other binding modes than
intercalation are bound to be present. The splitting of the N4´-methyl signal is thus expected to
result from either minor/major groove binding or surface binding.
One question still remains; which of the two signals from N4´-methyl results from the interacti-
on and which represents non-interacting Oflo?
Diffusion measurements performed on the N4´-methyl (a) signal indicated that some, but not all
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N4´-methyl groups giving rise to this signal are involved in some sort of interactions. If all were
involved the diffusion constant would be equal to that of pure GGCC and if non were involved
it would be equal to that of pure Oflo. Diffusion measurements were attempted on the N4´-met-
hyl (b) signal, but the uncertainty of the results is high due to the low intensities and the overlap
between the two N4´-methyl peaks and only the three last spectra in the titration could be meas-
ured. The diffusion constant measured from the N4´-methyl (b) signal appears to result in a dif-
fusion constant similar to pure GGCC (results not shown). The diffusion constants from N4´-met-
hyl (b) are highly uncertain and not dependable, but together with the diffusion measurements
from the N4´-methyl (a) displaying a diffusion constant not similar to neither pure Oflo nor pure
GGCC, leads to the conclusion that the N4´-methyl (b) signal is the signal from Oflo having N4´-
methyl groups interacting strongest with GGCC; binding in minor or major groove. Given the
poor coherence between fraction of Oflo intercalating calculated from the C3-methyl signal and
the N4´-methyl (b) signal, the N4´-methyl signal appears less likely to be splitted from the inter-
calation.
An interesting feature is that the N4´-methyl (b) signal is flattening out at the same Oflo:GGCC
ratio where intercalation is expected, indicating that the intercalation and the minor/major groo-
ve binding is somehow linked.
8.3.2 Titration of GGCC with Oflo
Unfortunately no NOESY spectra were recorded during the titration, but some information can
be gained from the 1H NMR spectra and the two NOESY spectra obtained. After the mishappe-
ning at the laboratory 390 microL of the sample was recovered. This volume was further diluted
to 450 microL giving an initial GGCC concentration of 0.48 mM.
Both 1D and 2D spectra immediately show a clear interaction between Oflo and GGCC. Some
signals are broadened, some disappear and some decrease or increase.
There is, of course, a possibility that the DNA no longer exists in the double helix state. Imino
crosspeaks are completely lost in the NOESY spectrum supporting this. But the T3 and T9 imino
signals in the 1H NMR spectra are never completely lost. Also, GGCC has a rather constant dif-
fusion constant being 1.33 ± 0.07 * 10-10 m2s-1 for pure GGCC and 1.4 ± 0.2 * 10-10 m2s-1 in the
final spectrum. Reports have shown that it is roughly a ratio of 0.65 between double
stranded:single stranded DNA diffusion constants[34], giving a diffusion constant of approxi-
mately 2 * 10-10 m2s-1 for single stranded GGCC. The ratio Oflo:GGCC in the final titration is 2.67
meaning that even if all of the Oflo in the solution are bound to GGCC, only 2.67 Oflo mole-
cules would be bound to each GGCC; this cannot account for such a low diffusion constant
unless GGCC is, in fact, in the double helix state.
The loss of NOESY crosspeaks strongly indicates intercalative mode of interaction. The broade-
ning of the guanine signals and the disappearing crosspeaks between the guanines and between
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the guanines and the thymine and adenine  in the NOESY spectrum further indicate intercalati-
on between the two guanines. The loss of proton signals from the guanines in the 1D spectra may
also indicate interactions in this site. The crosspeaks are symmetrically missing around the two
guanines in table 7.11 supporting intercalation between the guanine base pairs.
An intercalative mode is also supported by the drift in the chemical shifts of T1 and T9, as seen
in figure 7.19. The two signals T1 and T9 are drifting at Oflo:GGCC ratios above 1. The C3-met-
hyl signal is splitted in this same concentration range, leading to two conclusions; the intercalati-
on does not take place until the Oflo:GGCC ratio is around 1 and the splitting of the C3-methyl
signal is caused by intercalation.
The C3-methyl signal was investigated and the fraction of Oflo represented by the lowest peak,
as well as the association constants being calculated. The high association constants calculated
from this peak supports the theory that this splitting results from intercalation. The C3-methyl sig-
nal appears at 1.48 ppm for pure Oflo and from the two signals from N4´-methyl it is concluded
that the upfield signal is the signal from the interaction. The upfield signal, that is C3-methyl (b)
is thus the signal shifted from intercalation interactions. The C3-methyl signal is a doublet and is
almost not appearing in the diffusion spectra; therefore no diffusion measurements have been per-
formed on these signals.
Table 7.13 shows downfield shifts of the signals resulting from H1’, H2’ and H2’’ on the sugar to
which A2 is attached. T9 is not shifted in the same amount, indicating that the minor/major gro-
ove interaction takes place somewhere in the region T1A2T3-A8T9A10. It is more probable that
the interaction occurs between A2/T9 and T3/A8 since the outer base pairs are less stable. This
theory is also supported by the strong drift of the H2’’ on the sugar to which T3 is attached.
8.4 Association constants
Association constants have been calculated from three different sources. The three entirely diffe-
rent results as to percentage interaction Oflo:GGCC indicates the presence of three different
mechanisms of action. This is further discussed in the next chapter.
The association constants are confirming the assumptions that the split of C3-methyl arise from
intercalation and the split of N4´-methyl from minor/major groove binding, since intercalation
are expected to give rise to higher association constants.
Discussion
94
8.5 Models of interaction between quinolones and DNA
8.5.1 Proposal of a model of interaction between Oflo and GGCC
Tables 7.15, 7.16 and 7.17 indicates overlap of measurements. If there are three binding modes,
the fraction interacting Oflo would be nearly 100%, not being very likely from the diffusion con-
stant measured on the N4´-methyl (a) signal. The most reliable results are then the splitting of the
two signals from C3-methyl and N4´-methyl. These two splittings are not considered arising from
the same interaction. The two N4´-methyl peaks are visible from the very first spectrum, where-
as the two C3-methyl doublets are not observed until an Oflo:GGCC ratio of approximately 1:1.
This indicates that the N4´-methyl signal is splitted due to a binding in the minor/major groove
or surface binding, while the splitting of the C3-methyl comes from an intercalation interaction.
The diffusion measurements were performed on the N4´-methyl (a) signal not considered to
result from minor/major groove- or surface interactions and thus considered to display intercala-
ting Oflo. Table 7.15 shows the fraction intercalating Oflo calculated from the diffusion constant
whereas the fraction intercalating Oflo calculated from the splitting of the C3-methyl signal is
shown in table 7.16. The C3-methyl calculations display a larger fraction Oflo intercalating at all
Oflo:GGCC ratios. The diffusion constant has a high uncertainty, especially at lowered concen-
trations. The diffusion measurements were performed on a splitted peak with heavy overlap, and
were therefore not imbedded in this model.
The development of the N4´-methyl (b) peak maps the minor/major groove binding mode.
Before reaching a 1:1 ratio Oflo:GGCC the peak grows faster than after this ratio and at the ratio
hardly grows at all, indicating a rather constant minor/major groove interaction, except when the
intercalation mode is beginning.
The development of the C3-methyl (b) peak shows a rather constant intercalation mode. The
intercalation starts at a high rate and decays constantly, expected to level out when all intercalati-
on sites are occupied. Two intercalation sites are expected on each DNA, between the guanines in
each strand (this is not proved in this thesis as the concentration levels of Oflo is not high enough, but the post-
ulation of more than one intercalation site is supported by the fact that in the final spectrum 1.13 Oflo per GGCC
is calculated to interact).
This leads to the following model:
Below 1:1 ratio Oflo:GGCC:
Even at very diluted concentrations Oflo binds in the minor or major groove of the oligomer.
This is the only interaction between Oflo and GGCC at these concentration levels. The
minor/major groove interaction occurs somewhere in the T1A2T3-A8T9A10 region of the oli-
gomer.
At 1:1 ratio Oflo:GGCC:
Oflo intercalates in the oligomer between the guanine pairs. The minor/major groove binding is
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affected by the intercalation reaction and is merely acting as a reaction pathway at this ratio.
Above 1:1 ratio Oflo:GGCC:
Both intercalation and minor/major groove interactions appear. There is more than one interca-
lation site in each oligomer. The two interaction mechanisms are not seemingly competing, but
the major/minor groove binding continues at a slower rate after the intercalation starts, indicating
that they are in some way depending on each other.
8.5.2 Other possible models of interaction.
The results do not give enough information to arrive at an undisputable model, but there are
enough indices to propose a model for the interaction between Oflo and GGCC. The model must
thus be considered indicating, but not finally proved.
The interaction proposed disregards the diffusion constant measurements. If, on the other hand
they are not to be disregarded, there are not two but three mechanisms of interaction. The per-
centage interacting Oflo calculated from the diffusion constant may be true meaning that minor
or major groove binding is splitting the N4´-methyl signal and the other (minor/major) are not, or
the minor/major interaction is splitting the signal whilst a surface binding mode is not. In the first
case Oflo binds in both minor and major groove from very diluted concentrations and it is pos-
sible to monitor the development of both. From figure 7.13 it is then possible to see that the gro-
ove binding that splits the signal is somewhat dependent on the intercalation and the groove bin-
ding giving signal at the same frequency as non-interacting Oflo is not. At Oflo:GGCC ratio 1.03
approximately all of the Oflo present is then involved in interactions with GGCC. This is sup-
ported by the diffusion constant measurements on the peaks at 3.5 ppm and 8.4 ppm (results not
shown).
No crosspeaks between Oflo and GGCC are found in the NOESY spectrum. This is somewhat
strange if Oflo is interacting with GGCC through both intercalation sites, minor/major groove
binding and perhaps even surface binding.
Oflo is in fact a racemic mixture, complicating the models of interaction. The S-isomer is repor-
ted to be 3 - 4 times more reactive against DNA than the R-isomer[9]. The split of either the N4´-
methyl or the C3-methyl signal may arise from the two diastereomers being distinct while binding.
Since the C3-methyl group is situated at the chiral centre, its signal may be shifted due to this
effect. The two isomers are expected (but not confirmed) to be present in equal amounts. Table 7.16
are then, if all S-isomers are interacting with DNA, displaying the percentages of S-isomers ver-
sus R-isomers, though not indicating where or how Oflo is interacting and this is read out from
the split of the N4´-methyl signal. There are still two different interaction mechanisms;
minor/major groove binding and intercalation. Both mechanisms are functioning even at very dil-
uted concentrations.
This model is less likely since the T1 and T9 signals in figure 7.19 does not indicate intercalation
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until Oflo:GGCC ratio 1. Also the association constants for the intercalation are expected to be
higher than for the minor/major groove interactions. This is not the case in this model. Even
though this model cannot be disregarded as no proves can be put forward to eliminate it, it seems
less likely than the model already proposed.
8.5.3 The proposed model in comparison to models from the literature
8.5.3.1 The Shen model
Shen et al. proposed that DNA-gyrase produced single stranded fragments where quinolones
could interact. They also proposed that the intercalations of the quinolones are a cooperative pro-
cess with stacking interactions making stable complexes with four quinolones in each DNA helix.
No other interaction modes between quinolone and DNA were proposed.
The ratio Oflo:GGCC is not high enough to predict whether four quinolones may interact in one
DNA, but there is no sign of a cooperative intercalation. All intercalation sites in one DNA would
then have been filled up before intercalation in another DNA. The NOESY spectrum indicates
that all of, or at least most of the DNA present is intercalated. No crosspeaks from non-interca-
lated GGCC is observed even when investigating the baseline. Also, the results in this thesis indi-
cate several interaction modes. The presence of minor/major groove interactions is contradicto-
ry to that proposed by Shen et al..
8.5.3.2 The Maxwell model
Maxwell et al. proposed that quinolones could not interact with Gyrase or DNA alone, but could
only interact with the DNA-Gyrase complex. They proposed that two quinolones was intercala-
ting in a “DNA-bubble” created by the Gyrase approximately four or five base pairs away. They
also performed experiments with Ca2+ indicating that drug induced cleavage is only occurring
when the appropriate DNA base sequence exists at the active site.
The results in this thesis clearly show that quinolone may interact with DNA without the presen-
ce of DNA-gyrase. Without the Gyrase no “DNA-bubble” is formed, but the proposal of two
quinolones intercalating some base pairs away could be in coherence with the results of this the-
sis. No experiments on metal ions were performed in this thesis and thus no conclusions may be
drawn on whether presence of Ca2+ is necessary for DNA cleavage.
8.5.3.3 The Nordén model
Nordén et al. proposed a model where the intercalation is not a traditional one, but where the
DNA is deformed at the binding site. They concluded with only one binding site and excluded
both minor groove interactions and surface binding interactions. They found that quinolones
could interact with DNA without the presence of Gyrase or metal-ions.
The results in this thesis clearly show that quinolones may interact with DNA without the pre-
sence of DNA-Gyrase or metal ions. The proposed model in this thesis indicates minor or major
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groove interactions, but no crosspeaks are found supporting this conclusion. No evidence is
found found indicating that DNA is not deformed. On the contrary, it may in fact appear that the
DNA is deformed after intercalation as most of the crosspeaks between base pairs are lost and
internal crosspeaks in base pairs are either lost or shifted heavily. The results of this thesis can-
not counter-prove the Nordén model in any way, nor can it support all its findings.
8.5.3.4 Other models
A great deal of the models are based on the presence of metal ions. These models cannot be total-
ly disregarded, as paramagnetic impurities were not removed from the sample. There is no way of
telling whether the results in this thesis are a result of paramagnetic metal-ions making quinolo-
ne-DNA interactions possible. Since the nature of the paramagnetic impurities and the concen-
tration of the impurities are not known it is not possible to discuss this problem in detail.
Baily et al. reported that intercalation of the quinolone was sequence dependent, preferably inter-
calating between a guanine and a cytosine. The results in this thesis show that more than one
quinolone may intercalate in the DNA sequence. There exist indications that the intercalation is
between the two guanines rather than guanine and cytosine, but intercalation between guanine and
cytosine cannot be excluded. The results of this thesis are therefore not thought to support the
findings of Baily et al..
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8.6 Suggestions for further work
The properties of Ofloxacin should be further investigated. This thesis fails to conclude whether
the coalescence arises from hindering of ring rotation or ring inversion. One way to investigate
this might be to run HSQC and HMQC NMR experiments on lowered temperatures to assign the
2´/6´ protons to the C2´ and C6´. Molecular dynamics could also be investigated by molecular
modelling to find which of the two possible causes for the coalescence is energetically favourable.
Though Oflo is an extensively used antimicrobial, few reports have been made on the chemical
properties of the molecule using NMR. Mucci et al. is a fair exception. The pKa-values should be
confirmed and the microspecies found, this would be a valuable experiment. Also, Oflo being a
racemic mixture, has two isomers that should be investigated separately as they are reported to
behave rather differently. It is nearly impossible to distinguish the two in an NMR spectrum.
Separation is necessary in order to tell whether only one or both isomers have the same interacti-
on modes. DECODES (Diffusion encoded spectroscopy)[36] could be attempted, but wether this
technique applies to isomers are uncertain.
The interaction between Oflo and GGCC was difficult to investigate, due to the complete loss of
crosspeaks between the two. There is no doubt though, that interactions occur. To investigate the
interaction further it would be preferable to use a non-palindromic DNA-sequence. The GGCC-
oligomer is heavily distorted around the GGCC base pairs and there are no actual means to tell
whether the intercalation is between the guanines or between the neighbouring guaning and cyto-
sine. The choice of a non-palindromic sequence with only one GG site could also answer the
question of how many intercalation sites are present and how many Ofloxacin molecules could
intercalate at one site.
The use of 19F NMR diffusion measurements could also solve the problem of not knowing how
big a fraction of the Oflo is actually interacting. The experiments in this thesis clearly shows that
Oflo and GGCC have mostly overlapping proton signals, the only exception being N4´-methyl
which is not trustworthy from splittings and low concentration levels. The concentration levels
should be raised.
The recommendation must thus be to repeat the Oflo-GGCC titration. The next time one should
use a non-palindromic DNA oligomer preferably with one GG site and one ATA site to check for
intercalation and minor/major groove interactions and perform the experiments on both Oflo
isomers separate. NOESY spectra should be recorded in all titrations.
The experiments should also be repeated with the metal ions present to monitor if any differen-
ce in the interacting mode occur.
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- The self-diffusion constant of Ofloxacin is  4.36 (±0.06) * 10-10 m2/s  in
the 1 - 6 mM concentration range
- There is no change in the stacking conditions for Ofloxacin in the con-
centration range 1 - 6 mM.
- The self-diffusion constant of the DNA-oligomer GGCC is 1.34 (±0.07) *
10-10 m2/s
- Ofloxacin interacts with double-stranded DNA.
- Ofloxacin and GGCC interact through intercalation and at least one more
interaction mechanism.
Conclusions
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A1.1 Simfit and Regression plot for calculation of diffusion constant of GGCC using
peak at 7.12 ppm
Table A1.1 Information obtained to calculate diffusion constant for pure GGCC using the peak
at 7.12 ppm
* The spectrum was rendered by ringing and intensities could not be read out.
Table A1.2 Settings for instrumental parameters
A1. Plots from results
Gradient
strength 
0
2.252
4.503
6.755
9.007
11.26
13.51
15.76
18.01
20.27
22.52
24.77
27.02
29.27
31.52
33.78
36.03
38.28
40.53
42.78
45.03
Intensities
(absolut)
--*
32236
35664
28512
27796
25696
24356
22472
20664
18380
16468
14524
13100
10612
8504
7148
6132
5300
3712
3424
2316
Normalised
intensities
0.9039
1.0000
0.7995
0.7794
0.7205
0.6829
0.6301
0.5794
0.5154
0.4618
0.4072
0.3673
0.2976
0.2384
0.2004
0.1719
0.1486
0.1041
0.0960
0.0649
Y
Ln (I/I0)
0.1011
0.0000
0.2238
0.2492
0.3278
0.3814
0.4619
0.5457
0.6629
0.7727
0.8983
1.0015
1.2122
1.4336
1.6073
1.7606
1.9064
2.2626
2.3433
2.7343
X
(see eq. 5 - 10)
48550708
194116605
436827026
776638863
1213767695
1747308104
2377777534
3105175985
3933383490
4855070778
5873687087
6989232416
8201706767
9511110138
10923909251
12427601459
14028222688
15725772937
17520252207
19411660498
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Figure A1.1 Simfit and Regression plot for diffusion measurements of GGCC for peak at 7.12 ppm. The
point at Gradient strength 2.252 is not included in the plots.
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A1.2 Simfit and Regression plot for calculation of diffusion constant of GGCC using
peak at 7.81 ppm
Table A1.3 Information obtained to calculate diffusion constant for pure GGCC using the peak
at 7.81 ppm
* The spectrum was rendered by ringing and intensities could not be read out.
Table A1.4 Settings for instrumental parameters
Gradient
strength 
0
2.252
4.503
6.755
9.007
11.26
13.51
15.76
18.01
20.27
22.52
24.77
27.02
29.27
31.52
33.78
36.03
38.28
40.53
42.78
45.03
Intensities
(absolut)
--*
37936
32624
36508
36540
34480
32160
29312
26836
24528
21008
18436
16672
13080
11976
9224
8072
6592
5264
4276
3176
Normalised
intensities
1
0.8600
0.9624
0.9632
0.9089
0.8477
0.7727
0.7074
0.6466
0.5538
0.4860
0.4395
0.3448
0.3157
0.2431
0.2128
0.1738
0.1388
0.1127
0.0837
Y
Ln (I/I0)
0
0.1509
0.0384
0.0375
0.0955
0.1652
0.2579
0.3462
0.4361
0.5910
0.7216
0.8222
1.0648
1.1530
1.4141
1.5475
1.7500
1.9750
2.1829 
2.4803
X
(see eq. 5 - 10)
491539530
436827026
776638862
1213767695
1747308104
2377777534
3105175985
3933383490
4855070778
5873687087
6989232416
8201706767
9511110138
10923909251
12427601459
14028222688
15725772937
17520252207
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Figure A1.2 Simfit and Regression plot for diffusion measurements of GGCC for peak at 7.12 ppm. The
point at Gradient strength 4.503 is not included in the plots.
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A1.3 Simfit and Regression plot for calculation of diffusion constant of GGCC using
peak at 8.18 ppm
Table A1.5 Information obtained to calculate diffusion constant for pure GGCC using the peak
at 8.18 ppm
* The spectrum was rendered by ringing and intensities could not be read out.
Table A1.6 Settings for instrumental parameters
Gradient
strength 
0
2.252
4.503
6.755
9.007
11.26
13.51
15.76
18.01
20.27
22.52
24.77
27.02
29.27
31.52
33.78
36.03
38.28
40.53
42.78
45.03
Intensities
(absolut)
--*
18044
15820
17772
16664
15048
14640
13316
12036
11004
10048
8928
7104
6364
5344
4724
3632
2760
1816
1992
1452
Normalised
intensities
1
0.8767
0.9849
0.9235
0.8340
0.8114
0.7380
0.6670
0.6098
0.5569
0.4948
0.3937
0.3527
0.2962
0.2618
0.2013
0.1530
0.1006
0.1104
0.0805
Y
Ln (I/I0)
0
0.1315
0.0152
0.0796
0.1816
0.2091
0.3038
0.4049
0.4946
0.5854
0.7036
0.9322
1.0422
1.2168
1.3402
1.6030
1.8776
2.2962
2.2037
2.5199
X
(see eq. 5 - 10)
48550708
194116605
436827026
776638863
1213767695
1747308104
2377777534
3105175985
3933383490
4855070778
5873687087
6989232416
8201706767
9511110138
10923909251
12427601459
14028222688
15725772937
17520252207
19411660498
Little delta
2.3 milliseconds
Big delta
65 milliseconds
Tau
500 microsecond
Gamma
4357 Hz/Gauss
Max Gradient
70 Gauss/cm
Figure A1.3 Simfit and Regression plot for diffusion measurements of GGCC for peak at 7.12 ppm. The
point at gradient strengths 4.503 and 42.78 is not included in the plots.
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A1.4 Simfit and Regression plot for calculation of diffusion constant of GGCC using
peak at 8.28 ppm
Table A1.7 Information obtained to calculate diffusion constant for pure GGCC using the peak
at 8.28 ppm
* The spectrum was rendered by ringing and intensities could not be read out.
Table A1.8 Settings for instrumental parameters
Gradient
strength 
0
2.252
4.503
6.755
9.007
11.26
13.51
15.76
18.01
20.27
22.52
24.77
27.02
29.27
31.52
33.78
36.03
38.28
40.53
42.78
45.03
Intensities
(absolut)
--*
11924
10748
10272
11048
9716
9460
8580
7572
7008
6344
5396
4516
3640
3360
2644
1656
1836
1500
1280
836
Normalised
intensities
1
0.9014
0.8615
0.9265
0.8148
0.7934
0.7196
0.6350
0.5877
0.5320
0.4525
0.3787
0.3053
0.2818
0.2217
0.1389
0.1540
0.1258
0.1073
0.0701
Y
Ln (I/I0)
0
0.1038
0.1491
0.0763
0.2048
0.2315
0.3291
0.4541
0.5315
0.6310
0.7929
0.9709
1.1866
1.2666
1.5062
1.9741
1.8710
2.0731
2.2317
2.6577
X
(see eq. 5 - 10)
48550708
194116605
436827026
776638863
1213767695
1747308104
2377777534
3105175985
3933383490
4855070778
5873687087
6989232416
8201706767
9511110138
10923909251
12427601459
14028222688
15725772937
17520252207
19411660498
Little delta
2.3 milliseconds
Big delta
65 milliseconds
Tau
500 microsecond
Gamma
4357 Hz/Gauss
Max Gradient
70 Gauss/cm
Figure A1.4 Simfit and Regression plot for diffusion measurements of GGCC for peak at 8.28 ppm. The
points at gradient strengths 4.503, 6.755 and 36.03 is not included in the plots.
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A1.5 Simfit and Regression plot for calculation of diffusion constant of GGCC in Oflo-
GGCC mixture at Oflo:GGCC ratio 0.52 using peak at 7.12 ppm
Table A1.9 Information obtained to calculate diffusion constant for GGCC in Oflo-GGCC
mixture at Oflo:GGCC ratio 0.52 using the peak at 7.12 ppm
Table A1.8 Settings for instrumental parameters
Gradient
strength 
2.252
4.278
6.305
8.331
10.36
12.38
14.41
16.44
18.46
20.49
22.52
24.54
26.57
28.60
30.62
32.65
34.68
36.70
38.73
40.76
42.78
Intensities
(absolut)
11155
10423
11441
10831
10223
9311
9040
9529
8322
7119
6768
6711
4831
4911
3507
3802
3138
2140
2314
1596
1268
Normalised
intensities
0.9750
0.9111
1.0000
0.9467
0.8936
0.8138
0.7901
0.8329
0.7274
0.6223
0.5915
0.5866
0.4223
0.4292
0.3066
0.3323
0.2742
0.1870
0.2023
0.1395
0.1108
Y
Ln (I/I0)
0.0253
0.0931
0.0000
0.0548
0.1125
0.2060
0.2356
0.1828
0.3182
0.4744
0.5251
0.5334
0.8621
0.8458
1.1823
1.1016
1.2937
1.6765
1.5980
1.9698
2.1998
X
(see eq. 5 - 10)
43629766
157444565
341992274
597090804
923348449
1318522067
1786380934
2325143384
2931632358
3611852697
4362976619
5180780949
6073362759
7036848152
8065967838
9170911120
10346757985
11587193026
12904497779
14292706116
15744456514
Little delta
2.5 milliseconds
Big delta
50 milliseconds
Tau
500 microsecond
Gamma
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Max Gradient
70 Gauss/cm
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Figure A1.5 Simfit and Regression plot for diffusion measurements of GGCC in Oflo-GGCC mixture with
Oflo:GGCC ratio 0.52 using peak at 7.12 ppm. All points are included in the plots.
Appendix A.1 Plots from results
109
A1.6 Simfit and Regression plot for calculation of diffusion constant of GGCC in Oflo-
GGCC mixture at Oflo:GGCC ratio 0.52 using peak at 7.81 ppm
Table A1.9 Information obtained to calculate diffusion constant for GGCC in Oflo-GGCC
mixture at Oflo:GGCC ratio 0.52 using the peak at 7.81 ppm
Table A1.8 Settings for instrumental parameters
Gradient
strength 
2.252
4.278
6.305
8.331
10.36
12.38
14.41
16.44
18.46
20.49
22.52
24.54
26.57
28.60
30.62
32.65
34.68
36.70
38.73
40.76
42.78
Intensities
(absolut)
9895
9015
8916
9354
8965
8452
8518
7966
7498
6313
6454
5313
4937
4313
3936
3567
3389
2238
2194
1545
1469
Normalised
intensities
1.0000
0.9110
0.9011
0.9454
0.9060
0.8542
0.8608
0.8050
0.7578
0.6379
0.6523
0.5369
0.4989
0.4358
0.3978
0.3605
0.3425
0.2262
0.2218
0.1562
0.1485
Y
Ln (I/I0)
0.0000
0.0932
0.1041
0.0562
0.0987
0.1576
0.1499
0.2169
0.2773
0.4495
0.4273
0.6220
0.6954
0.8305
0.9218
1.0202
1.0716
1.4864
1.5062
1.8568
1.9073
X
(see eq. 5 - 10)
43629766
157444565
341992274
597090804
923348449
1318522067
1786380934
2325143384
2931632358
3611852697
4362976619
5180780949
6073362759
7036848152
8065967838
9170911120
10346757985
11587193026
12904497779
14292706116
15744456514
Little delta
2.5 milliseconds
Big delta
50 milliseconds
Tau
500 microsecond
Gamma
4357 Hz/Gauss
Max Gradient
70 Gauss/cm
Figure A1.6 Simfit and Regression plot for diffusion measurements of GGCC in Oflo-GGCC mixture with
Oflo:GGCC ratio 0.52 using peak at 7.81 ppm. All points are included in the plots.
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A1.7 Simfit and Regression plot for calculation of diffusion constant of GGCC in Oflo-
GGCC mixture at Oflo:GGCC ratio 0.52 using peak at 8.18 ppm
Table A1.11 Information obtained to calculate diffusion constant for GGCC in Oflo-GGCC
mixture at Oflo:GGCC ratio 0.52 using the peak at 8.18 ppm
Table A1.12 Settings for instrumental parameters
Gradient
strength
2.252
4.278
6.305
8.331
10.36
12.38
14.41
16.44
18.46
20.49
22.52
24.54
26.57
28.60
30.62
32.65
34.68
36.70
38.73
40.76
42.78
Intensities
(absolut)
5205
5977
5402
5156
4702
4514
4462
4170
3646
3207
3512
2492
2411
2478
1879
1948
1386
1088
698
1103
398
Normalised
intensities
0.8708
1.0000
0.9039
0.8626
0.7867
0.7552
0.7466
0.6978
0.6100
0.5366
0.5875
0.4170
0.4033
0.4146
0.3144
0.3260
0.2319
0.1820
0.1167
0.1846
0.0666
Y
Ln (I/I0)
0.1383
0.0000
0.1011
0.1478
0.2399
0.2808
0.2923
0.3599
0.4943
0.6225
0.5318
0.8747
0.9080
0.8806
1.1571
1.1209
1.4614
1.7039
2.1481
1.6896
2.7095
X
(see eq. 5 - 10)
43629766
157444565
341992274
597090804
923348449
1318522067
1786380934
2325143384
2931632358
3611852697
4362976619
5180780949
6073362759
7036848152
8065967838
9170911120
10346757985
11587193026
12904497779
14292706116
15744456514
Little delta
2.5 milliseconds
Big delta
50 milliseconds
Tau
500 microsecond
Gamma
4357 Hz/Gauss
Max Gradient
70 Gauss/cm
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Figure A1.7 Simfit and Regression plot for diffusion measurements of GGCC in Oflo-GGCC mixture with
Oflo:GGCC ratio 0.52 using peak at 8.18 ppm. All points are included in the plots.
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A1.8 Simfit and Regression plot for calculation of diffusion constant of GGCC in Oflo-
GGCC mixture at Oflo:GGCC ratio 0.52 using peak at 8.28 ppm
Table A1.13 Information obtained to calculate diffusion constant for GGCC in Oflo-GGCC
mixture at Oflo:GGCC ratio 0.52 using the peak at 8.28 ppm
Table A1.14 Settings for instrumental parameters
Gradient
strength 
2.252
4.278
6.305
8.331
10.36
12.38
14.41
16.44
18.46
20.49
22.52
24.54
26.57
28.60
30.62
32.65
34.68
36.70
38.73
40.76
42.78
Intensities
(absolut)
3595
3354
3234
4301
3680
2955
2929
3319
2677
2562
2955
1988
1721
1201
1146
1307
811
1121
877
644
486
Normalised
intensities
0.8357
0.7797
0.7518
1.0000
0.8556
0.6870
0.6809
0.7717
0.6223
0.5956
0.6870
0.4623
0.4001
0.2791
0.2663
0.3038
0.1885
0.2607
0.2039
0.1497
0.1130
Y
Ln (I/I0)
0.1795
0.2489
0.2852
0.0000
0.1559
0.3755
0.3843
0.2592
0.4743
0.5182
0.3755
0.7716
0.9160
1.2761
1.3230
1.1915
1.6689
1.3445
1.5902
1.8991
2.1803
X
(see eq. 5 - 10)
43629766
157444565
341992274
597090804
923348449
1318522067
1786380934
2325143384
2931632358
3611852697
4362976619
5180780949
6073362759
7036848152
8065967838
9170911120
10346757985
11587193026
12904497779
14292706116
15744456514
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Figure A1.8 Simfit and Regression plot for diffusion measurements of GGCC in Oflo-GGCC mixture with
Oflo:GGCC ratio 0.52 using peak at 8.28 ppm. All points are included in the plots.
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A1.9 Simfit and Regression plot for calculation of diffusion constant of GGCC in Oflo-
GGCC mixture at Oflo:GGCC ratio 2.67 using peak at 7.12 ppm
Table A1.15 Information obtained to calculate diffusion constant for GGCC in Oflo-GGCC
mixture at Oflo:GGCC ratio 2.67 using the peak at 7.12 ppm
Table A1.16 Settings for instrumental parameters
Gradient
strength 
2.252
4.278
6.305
8.331
10.36
12.38
14.41
16.44
18.46
20.49
22.52
24.54
26.57
28.60
30.62
32.65
34.68
36.70
38.73
40.76
42.78
Intensities
(absolut)
7501
8272
3783
9578
8783
7333
6951
6849
7195
5894
5273
5264
3242
2880
4081
2883
2843
1196
2431
611
1499
Normalised
intensities
0.7831
0.8636
0.3950
1.0000
0.9170
0.7656
0.7258
0.7151
0.7513
0.6154
0.5506
0.5496
0.3385
0.3007
0.4260
0.3010
0.2968
0.1249
0.2538
0.0638
0.1565
Y
Ln (I/I0)
0.2444
0.1466
0.9280
0.0000
0.0866
0.2671
0.3205
0.3354
0.2860
0.4854
0.5968
0.5986
1.0832
1.2015
0.8532
1.2005
1.2146
2.0805
1.3712
2.7524
1.8545
X
(see eq. 5 - 10)
43629766
157444565
341992274
597090804
923348449
1318522067
1786380934
2325143384
2931632358
3611852697
4362976619
5180780949
6073362759
7036848152
8065967838
9170911120
10346757985
11587193026
12904497779
14292706116
15744456514
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Figure A1.9 Simfit and Regression plot for diffusion measurements of GGCC in Oflo-GGCC mixture with
Oflo:GGCC ratio 2.67 using peak at 7.12 ppm. Point at gradient strength 6.305 are not included in the plots.
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A1.10 Simfit and Regression plot for calculation of diffusion constant of GGCC in Oflo-
GGCC mixture at Oflo:GGCC ratio 2.67 using peak at 7.81 ppm
Table A1.17 Information obtained to calculate diffusion constant for GGCC in Oflo-GGCC
mixture at Oflo:GGCC ratio 2.67 using the peak at 7.81 ppm
Table A1.18 Settings for instrumental parameters
Gradient
strength 
2.252
4.278
6.305
8.331
10.36
12.38
14.41
16.44
18.46
20.49
22.52
24.54
26.57
28.60
30.62
32.65
34.68
36.70
38.73
40.76
42.78
Intensities
(absolut)
6140
4695
4124
4581
4217
4148
4279
3100
3529
3399
3002
2550
2330
2082
1881
1909
1877
1226
1029
732
634
Normalised
intensities
1.0000
0.7646
0.6717
0.7460
0.6869
0.6756
0.6970
0.5049
0.5747
0.5535
0.4890
0.4153
0.3795
0.3391
0.3064
0.3110
0.3058
0.1996
0.1677
0.1192
0.1032
Y
Ln (I/I0)
0.0000
0.2684
0.3980
0.2930
0.3756
0.3922
0.3610
0.6833
0.5539
0.5914
0.7155
0.8786
0.9690
1.0815
1.1830
1.1681
1.1850
1.6112
1.7858
2.1269
2.2711
X
(see eq. 5 - 10)
43629766
157444565
341992274
597090804
923348449
1318522067
1786380934
2325143384
2931632358
3611852697
4362976619
5180780949
6073362759
7036848152
8065967838
9170911120
10346757985
11587193026
12904497779
14292706116
15744456514
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Figure A1.10 Simfit and Regression plot for diffusion measurements of GGCC in Oflo-GGCC mixture with
Oflo:GGCC ratio 2.67 using peak at 7.81 ppm. All points are included in the plots.
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A1.11 Simfit and Regression plot for calculation of diffusion constant of GGCC in Oflo-
GGCC mixture at Oflo:GGCC ratio 2.67 using peak at 8.18 ppm
Table A1.19 Information obtained to calculate diffusion constant for GGCC in Oflo-GGCC
mixture at Oflo:GGCC ratio 2.67 using the peak at 8.18 ppm
Table A1.20 Settings for instrumental parameters
Gradient
strength 
2.252
4.278
6.305
8.331
10.36
12.38
14.41
16.44
18.46
20.49
22.52
24.54
26.57
28.60
30.62
32.65
34.68
36.70
38.73
40.76
42.78
Intensities
(absolut)
1231
2516
1235
2555
2755
2579
2429
1697
1853
2300
1011
1939
1535
1382
799
1166
771
686
1003
965
477
Normalised
intensities
0.4467
0.9133
0.4481
0.9273
1.0000
0.9359
0.8815
0.6159
0.6726
0.8346
0.3669
0.7040
0.5570
0.5016
0.2900
0.4233
0.2798
0.2491
0.3642
0.3503
0.1731
Y
Ln (I/I0)
0.8058
0.0907
0.8027
0.0755
0.0000
0.0662
0.1261
0.4847
0.3966
0.1808
1.0028
0.3510
0.5853
0.6899
1.2380
0.8598
1.2737
1.3900
1.0102
1.0490
1.7536
X
(see eq. 5 - 10)
43629766
157444565
341992274
597090804
923348449
1318522067
1786380934
2325143384
2931632358
3611852697
4362976619
5180780949
6073362759
7036848152
8065967838
9170911120
10346757985
11587193026
12904497779
14292706116
15744456514
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Figure A1.11 Simfit and Regression plot for diffusion measurements of GGCC in Oflo-GGCC mixture with
Oflo:GGCC ratio 2.67 using peak at 8.18 ppm. All points are included in the plots.
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A1.12 Simfit and Regression plot for calculation of diffusion constant of GGCC in Oflo-
GGCC mixture at Oflo:GGCC ratio 2.67 using peak at 8.28 ppm
Table A1.21 Information obtained to calculate diffusion constant for GGCC in Oflo-GGCC
mixture at Oflo:GGCC ratio 2.67 using the peak at 8.28 ppm
Table A1.22 Settings for instrumental parameters
Gradient
strength 
2.252
4.278
6.305
8.331
10.36
12.38
14.41
16.44
18.46
20.49
22.52
24.54
26.57
28.60
30.62
32.65
34.68
36.70
38.73
40.76
42.78
Intensities
(absolut)
3487
3053
4246
2840
2456
2404
2554
2609
1575
1859
1806
1722
1537
1054
1235
780
754
612
536
510
816
Normalised
intensities
0.8213
0.7191
1.0000
0.6689
0.5784
0.5663
0.6016
0.6146
0.3710
0.4378
0.4254
0.4055
0.3620
0.2483
0.2908
0.1837
0.1776
0.1441
0.1262
0.1202
0.1922
Y
Ln (I/I0)
0.1968
0.3298
0.0000
0.4022
0.5474
0.5687
0.5082
0.4868
0.9916
0.8261
0.8547
0.9027
1.0160
1.3932
1.2351
1.6943
1.7280
1.9374
2.0702
2.1189
1.6492
X
(see eq. 5 - 10)
43629766
157444565
341992274
597090804
923348449
1318522067
1786380934
2325143384
2931632358
3611852697
4362976619
5180780949
6073362759
7036848152
8065967838
9170911120
10346757985
11587193026
12904497779
14292706116
15744456514
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Figure A1.12 Simfit and Regression plot for diffusion measurements of GGCC in Oflo-GGCC mixture with
Oflo:GGCC ratio 2.67 using peak at 8.28 ppm. All points are included in the plots.
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A2. Spectra from results
118
0123456789
Figure A2.1 7 mM Ofloxacin with pH 5.5 obtained using D2O as solvent without water suppression
A2.1 Spectrum obtained of Oflo in D2O
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
Figure A2.2 ~5mM Ofloxacin in water (10% D2O) with pH 4.92 obtained at 293.9 K (actual temperature)
with presaturation of the water signal.
2.9302.9402.9502.9602.9702.9802.9903.000
Figure A2.3 Expansions of the piperazine ring protons and the N4´-methyl protons from the spectrum above.
3.203.303.403.503.603.703.80
A2.2 Spectrum obtained of ~5 mM Oflo in water (10% D2O) with pH 4.92 and presatura-
tion of the water signal 
Appendix A2: Spectra from results
119
02468101214
Figure A2.4 1H NMR spectrum of ratio Oflo:GGCC 0.15.
12.2012.4012.6012.8013.0013.2013.4013.6013.80
1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.4
Figure A2.5 Expansion of the imino region from
figure A2.4.
Figure A2.6 Expansion of the 1.0 - 4.5 ppm regi-
on from figure A2.4. 
Figure A2.7 Expansion of the aromatic region from figu-
re A2.4.
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A2.3 Spectrum obtained for 0.07 mM Ofloxacin in 0.48 mM GGCC resulting in a 0.15 ratio
Oflo:GGCC
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7.207.407.607.808.008.208.408.608.809.00
02468101214
Figure A2.8 1H NMR spectrum of ratio Oflo:GGCC 0.27.
12.2012.4012.6012.8013.0013.2013.4013.6013.80
1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.4
7.207.407.607.808.008.208.40
Figure A2.10 Expansion of the aromatic region of
figure A2.8.
Figure A2.11 Expansion of the 1.0 - 4.5 ppm
region of figure A2.8
Figure A2.9 Expansion of the imino region of
figure A2.8.
A2.4 Spectrum obtained for 0.13 mM Ofloxacin in 0.47 mM GGCC resulting in a 0.27
ratio Oflo:GGCC
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A2.5 Spectrum obtained for 0.24 mM Ofloxacin in 0.46 mM GGCC resulting in a 0.52
ratio Oflo:GGCC
02468101214
Figure A2.12 S1H NMR spectrum of ratio Oflo:GGCC 0.52.
12.2012.4012.6012.8013.0013.2013.4013.6013.80
1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.4
Figure A2.13 Expansion of imino region 
Figure A2.14 Expansion of 1.0 - 4.5 ppm region of
figure A2.12
7.207.407.607.808.008.208.40
Figure A2.15 Expansion of aromatic region 
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A2.6 Spectrum obtained for 0.35 mM Ofloxacin in 0.45 mM GGCC resulting in a 0.77
ratio Oflo:GGCC
02468101214
Figure A2.16 1H NMR spectrum of ratio Oflo:GGCC 0.77
12.2012.4012.6012.8013.0013.2013.4013.6013.80
1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.4
Figure A2.19 Expansion of 1.0 - 4.5 ppm region
Figure A2.17 Expansion of imino region 
7.207.407.607.808.008.208.40
Figure A2.18 Expansion aromatic region
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A2.7 Spectrum obtained for 0.45 mM Ofloxacin in 0.44 mM GGCC resulting in a 1.03
ratio Oflo:GGCC
1234567891011121314
Figure A2.20 1H NMR spectrum of ratio Oflo:GGCC 1.03
12.2012.4012.6012.8013.0013.2013.4013.6013.80
Figure A2.21 Expansion of imino region 
7.207.407.607.808.008.208.40
Figure A2.22 Expansion of aromatic region 
1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.4
Figure A2.23 Expansion of 1.0 - 4.5 ppm
region
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1234567891011121314
A2.8 Spectrum obtained for 0.56 mM Ofloxacin in 0.43 mM GGCC resulting in a 1.29
ratio Oflo:GGCC
Figure A2.24 1H NMR spectrum of ratio Oflo:GGCC 1.29.
12.2012.4012.6012.8013.0013.2013.4013.6013.80
7.207.407.607.808.008.208.40
1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.4
Figure A2.25 Expansion of imino region 
Figure A2.26 Expansion of aromatic region 
Figure A2.27 Expansion of 1.0 - 4.5 ppm
region 
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A2.9 Spectrum obtained for 0.67 mM Ofloxacin in 0.42 mM GGCC resulting in a 1.56
ratio Oflo:GGCC
1234567891011121314
Figure A2.28 1H NMR spectrum of ratio Oflo:GGCC 1.56
12.2012.4012.6012.8013.0013.2013.4013.6013.80
Figure A2.29 Expansion of imino region 
7.207.407.607.808.008.208.40
Figure A2.30 Expansion of aromatic region 
1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.4
Figure A2.31 Expansion of 1.0 - 4.5 ppm region 
Appendix A2: Spectra from results
126
A2.10 Spectrum obtained for 0.77 mM Ofloxacin in 0.42 mM GGCC resulting in a 1.83
ratio Oflo:GGCC
1234567891011121314
Figure A2.32 1H NMR spectrum of ratio Oflo:GGCC 1.83.
12.2012.4012.6012.8013.0013.2013.4013.6013.80
Figure A2.33 Expansion of imino region 
7.207.407.607.808.008.208.40
Figure A2.34 Expansion of aromatic region 
1 21 41 61 82 02 22 42 62 83 03 23 43 63 84 04 24 4
Figure A2.35 Expansion of 1.0 - 4.5 ppm region 
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A2.11 Spectrum obtained for 0.86 mM Ofloxacin in 0.41 mM GGCC resulting in a 2.11
ratio Oflo:GGCC
1234567891011121314
Figure A2.36 1H NMR spectrum of ratio Oflo:GGCC 2.11
12.2012.4012.6012.8013.0013.2013.4013.6013.80
Figure A2.37 Expansion of imino region 
7.207.407.607.808.008.208.40
Figure A2.38 Expansion of aromatic region 
1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.4
Figure A2.39 Expansion of 1.0 - 4.5 ppm region
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A2.12 Spectrum obtained for 0.95 mM Ofloxacin in 0.40 mM GGCC resulting in a 2.39
ratio Oflo:GGCC
1234567891011121314
Figure A2.40 1H NMR spectrum of ratio Oflo:GGCC 2.39
12.2012.4012.6012.8013.0013.2013.4013.6013.80
Figure A2.41 Expansion of imino region 
7.207.407.607.808.008.208.40
Figure A2.42 Expansion of aromatic region 
1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.4
Figure A2.43 Expansion of 1.0 - 4.5 ppm region 
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A2.13 Spectrum obtained for 1.05 mM Ofloxacin in 0.39J mM GGCC resulting in a 2.67
ratio Oflo:GGCC
1234567891011121314
Figure A2.44 1H NMR spectrum of ratio Oflo:GGCC 2.67
12.2012.4012.6012.8013.0013.2013.4013.6013.80
Figure A2.45 Expansion of imino region 
7.207.407.607.808.008.208.40
Figure A2.46 Expansion of aromatic region 
1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.04.24.4
Figure A2.47 Expansion of 1.0 - 4.5 ppm region 
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B. Pulseprogrammes
B.1 1D 1H spectrum without water suppression
;zg
;avance-version
;1D sequence
#include <Avance.incl>
1 ze
2 d1
p1 ph1
go=2 ph31
wr #0
exit
ph1=0 2 2 0 1 3 3 1
ph31=0 2 2 0 1 3 3 1
;pl1 : f1 channel - power level for pulse (default)
;p1 : f1 channel -  high power pulse
;d1 : relaxation delay; 1-5 * T1
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B.2 1D 1H spectrum with presaturation of water
;zgpr
;avance-version
;1D sequence with f1 presaturation
#include <Avance.incl>
“d12=20u”
“d13=3u”
1 ze
2 d12 pl9:f1
d1 cw:f1
d13 do:f1
d12 pl1:f1
p1 ph1
go=2 ph31
wr #0
exit
ph1=0 2 2 0 1 3 3 1
ph31=0 2 2 0 1 3 3 1
;pl1 : f1 channel - power level for pulse (default)
;pl9 : f1 channel - power level for presaturation
;p1 : f1 channel -  90 degree high power pulse
;d1 : relaxation delay; 1-5 * T1
;d12: delay for power switching                      [20 usec]
;d13: short delay                                    [3 usec]
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B.3 1D 1H NMR spectrum with w5 water suppression 
;dpfgsew5
;avance-version
;1D sequence
;water suppression using w5 pulse sequence with gradients
;and excitation sculpting
;
;
; M. Liu, X. Mao, C. Ye, H. Huang, J.K. Nicholson and J.C. Lindon,
; J. Magn. Reson., 132, 125-129 (1998)
;
; T.-L. Hwang & A.J. Shaka, J. Magn. Reson.,
; Series A 112, 275-279 (1995).
;
;
#include <Avance.incl>
#include <Grad.incl>
1 ze
2 d1 pl1:f1
p1 ph1
50u UNBLKGRAD
GRADIENT(cnst21)
d16 pl18:f1
p28*0.0867 ph3
d19*2
p28*0.2056 ph3
d19*2
p28*0.4133 ph3
d19*2
p28*0.7778 ph3
d19*2
p28*1.4911 ph3
d19*2
p28*1.4911 ph4
d19*2
p28*0.7778 ph4
d19*2
p28*0.4133 ph4
d19*2
p28*0.2056 ph4
d19*2
p0*0.0867 ph4
50u
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GRADIENT(cnst22)
d16
50u
GRADIENT(cnst23)
d16
p28*0.0867 ph3
d19*2
p28*0.2056 ph3
d19*2
p28*0.4133 ph3
d19*2
p28*0.7778 ph3
d19*2
p28*1.4911 ph3
d19*2
p28*1.4911 ph4
d19*2
p28*0.7778 ph4
d19*2
p28*0.4133 ph4
d19*2
p28*0.2056 ph4
d19*2
p0*0.0867 ph4
46u
GRADIENT(cnst24)
d16
4u BLKGRAD
go=2 ph31
wr #0
exit
ph1=0 2
ph3=0
ph4=2
ph31=0 2
;pl1 : f1 channel - power level for pulse (default)
;pl18: f1 channel - power level for w5-pulse
;p0 : f1 channel -  90 degree pulse at pl18
; use for fine adjustment
;p1 : f1 channel -  90 degree high power pulse
;p16: homospoil/gradient pulse
;p28: f1 channel -  90 degree pulse at pl18
;d1 : relaxation delay; 1-5 * T1
;d16: delay for homospoil/gradient recovery
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;d19: delay for binomial water suppression
; d19 = (1/(2*d)), d = distance of next null (in Hz)
;NS: 8 * n
;DS: 4
;use gradient program (GRDPROG) : 4sine
;use gradient ratio: cnst21 : cnst22 : cnst23 : cnst24 
; 40 : 40 : 7 : 7
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B.4 Spin echo diffusion measurement with w5 water suppression
;segsw5
;avance-version
;2D sequence for diffusion measurement using standard PGSE
;
;water suppression using w5 pulse sequence with gradients
;M. Piotto, V. Saudek & V. Sklenar, J. Biomol. NMR 2, 661 - 666 (1992)
;M. Liu, X. Mao, C. Ye, H. Huang, J.K. Nicholson and J.C. Lindon,
;J. Magn. Reson., 132, 125-129 (1998)
#include <Avance.incl>
#include <Grad.incl>
“ds=l20”
1  ze
2  d1 pl1:f1 BLKGRAD
3  50u UNBLKGRAD
p1 ph1
GRADIENT(cnst21)
d16 pl18:f1
p28*0.0867 ph3
d19*2
p28*0.2056 ph3
d19*2
p28*0.4133 ph3
d19*2
p28*0.7778 ph3
d19*2
p28*1.4911 ph3
d19*2
p28*1.4911 ph4
d19*2
p28*0.7778 ph4
d19*2
p28*0.4133 ph4
d19*2
p28*0.2056 ph4
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d19*2
p0*0.0867 ph4
46u
GRADIENT(cnst21)
d16
4u BLKGRAD
go=2 ph31 
d1 wr #0 if #0 zd
lo to 3 times td1
exit
ph1=0 0 1 1 2 2 3 3
ph3=1 3 2 0 3 1 0 2 
ph4=3 1 0 2 1 3 2 0
ph31=0 0 1 1 2 2 3 3
;pl1 : f1 channel - power level for pulse (default)
;pl18: f1 channel - power level for 3-9-19-pulse (watergate)
;p0 : f1 channel -  90 degree pulse at pl18
; use for fine adjustment
;p1 : f1 channel -  high power pulse
;p16: gradient pulse (little DELTA)
;p28: f1 channel -  90 degree pulse at pl18
;d1 : relaxation delay; 1-5 * T1
;d16: delay for gradient recovery
;d19: delay for binomial water suppression
; d19 = (1/(2*d)), d = distance of next null (in Hz)
;l20: dummy scans (ds)
;NS: 2 * n
;DS: l20
;td1: number of experiments
;MC2: use xf2 and ilt for processing
;use gradient program (GRDPROG) : Se
;use AU-program dosy or dosyq to calculate gradient-file dramp
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B.5 Stimulated spin echo diffusion measurement with 3-9-19 water suppression
;ledbp19gs2s.nf
;avance-version
;2D sequence for diffusion measurement using stimulated 
; echo and LED
;using bipolar gradient pulses for diffusion
;using 2 spoil gradients
;D. Wu, A. Chen & C.S. Johnson Jr.,
; J. Magn. Reson. A 115, 260-264 (1995).
;
;
;water suppression using 3-9-19 pulse sequence with gradients
;M. Piotto, V. Saudek & V. Sklenar, J. Biomol. NMR 2, 661 - 666 (1992)
;V. Sklenar, M. Piotto, R. Leppik & V. Saudek, J. Magn. Reson.,
; Series A 102, 241 -245 (1993)
#include <Avance.incl>
#include <Grad.incl>
“p2=p1*2”
“d30=d21-p19-d16-4u”
“d31=d20-p1*2-d19*10-p28*4.539-p0*0.231-p16*2-d16*3-p19”
1 ze
2 d1 BLKGRAD
3 50u UNBLKGRAD
p1 ph1
GRADIENT(cnst21)
d16 pl18:f1
p28*0.231 ph11
d19*2
p28*0.692 ph11
d19*2
p28*1.462 ph11
d19*2
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p28*1.462 ph12
d19*2
p28*0.692 ph12
d19*2
p0*0.231 ph12
GRADIENT(-cnst21)
d16 pl1:f1
p1 ph2
GRADIENT2(cnst22)
d16
d31
p1 ph3
GRADIENT(cnst21)
d16 
p2 ph1
GRADIENT(-cnst21)
d16
p1 ph4
GRADIENT2(cnst23)
d16
d30
4u BLKGRAD
p1 ph5
go=2 ph31
d1 wr #0 if #0 zd
lo to 3 times td1
exit
ph1 = 0
ph11= 0
ph12= 2
ph2 = 0 0 2 2
ph3 = 0 0 0 0 2 2 2 2 1 1 1 1 3 3 3 3
ph4 = 0 2 0 2 2 0 2 0 1 3 1 3 3 1 3 1
ph5 = 0 0 0 0 2 2 2 2 1 1 1 1 3 3 3 3
ph31= 0 2 2 0 2 0 0 2 3 1 1 3 1 3 3 1
;pl1 : f1 channel - power level for pulse (default)
;pl18: f1 channel - power level for 3-9-19-pulse (watergate)
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;p0 : f1 channel -  90 degree pulse at pl18
; use for fine adjustment
;p1  : f1 channel -  90 degree high power pulse
;p2  : f1 channel - 180 degree high power pulse
;p16: gradient pulse (little DELTA)
;p19: gradient pulse 2 (spoil gradient)
;p17: gradient pulse 3 (Watergate)
;p28: f1 channel -  90 degree pulse at pl18
;d1  : relaxation delay; 1-5 * T1
;d16: delay for gradient recovery
;d20: diffusion time (big DELTA)
;d21: eddy current delay (Te) [5 ms]
;d30: d21 - p19 - d16 - 4u
;d31: d20 - p1*2 - d19*10 - p28*4.539 - p0*0.231 - p16*2 - d16*3 - p19
;l20: dummy scans (ds)
;NS: 8 * n
;DS: l20
;td1: number of experiments
;MC2: use xf2 and ilt for processing
;use gradient program (GRDPROG) : Ledbp2s
;use gradient ratio: cnst22 : cnst23
; -13.17 : -17.13
;use AU-program dosy or dosyq to calculate gradient-file dramp
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B.6 2D NOESY with w5 water suppression
;noesydpfgsew5
;avance-version
;2D homonuclear correlation via dipolar coupling 
;dipolar coupling may be due to noe or chemical exchange.
;phase sensitive using States-TPPI method
;water suppression using w5 pulse sequence with gradients
;and excitation sculpting
;
;
; M. Liu, X. Mao, C. Ye, H. Huang, J.K. Nicholson and J.C. Lindon,
; J. Magn. Reson., 132, 125-129 (1998)
;
; T.-L. Hwang & A.J. Shaka, J. Magn. Reson.,
; Series A 112, 275-279 (1995).
;
;
#include <Avance.incl>
#include <Grad.incl>
;;”d0=3u”
;;”d11=30m”
;;”d12=20u”
“d0=in0/2-p1*4/3.14159265”
“l3=(td1/2)”
1 ze
2 d1
3 d11
4 d12 pl1:f1
p1 ph1
d0
p1 ph2
d8
p1 ph3
d12 pl18:f1
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50u UNBLKGRAD
GRADIENT(cnst21)
d16
p28*0.0867 ph4
d19*2
p28*0.2056 ph4
d19*2
p28*0.4133 ph4
d19*2
p28*0.7778 ph4
d19*2
p28*1.4911 ph4
d19*2
p28*1.4911 ph5
d19*2
p28*0.7778 ph5
d19*2
p28*0.4133 ph5
d19*2
p28*0.2056 ph5
d19*2
p0*0.0867 ph5
50u
GRADIENT(cnst22)
d16
50u
GRADIENT(cnst23)
d16
p28*0.0867 ph4
d19*2
p28*0.2056 ph4
d19*2
p28*0.4133 ph4
d19*2
p28*0.7778 ph4
d19*2
p28*1.4911 ph4
d19*2
p28*1.4911 ph5
d19*2
p28*0.7778 ph5
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d19*2
p28*0.4133 ph5
d19*2
p28*0.2056 ph5
d19*2
p0*0.0867 ph5
46u
GRADIENT(cnst24)
d16
4u BLKGRAD
go=2 ph31
d1 wr #0 if #0 ip1 zd
lo to 3 times 2
d11 id0
lo to 4 times l3
exit
ph1=0 2 
ph2=0 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2
ph3=0 0 2 2 1 1 3 3
ph4=0
ph5=2
ph31=0 2 2 0 1 3 3 1 2 0 0 2 3 1 1 3
;pl1 : f1 channel - power level for pulse (default)
;pl18: f1 channel - power level for 3-9-19-pulse (watergate)
;p0 : f1 channel -  90 degree pulse at pl18
; use for fine adjustment
;p1 : f1 channel -  90 degree high power pulse
;p2 : f1 channel - 180 degree high power pulse
;p16: homospoil/gradient pulse
;p28: f1 channel -  90 degree pulse at pl18
;d0 : incremented delay (2D)                         [3 usec]
;d1 : relaxation delay; 1-5 * T1
;d8 : mixing time
;d11: delay for disk I/O                             [30 msec]
;d12: delay for power switching                      [20 usec]
;d16: delay for homospoil/gradient recovery
;d19: delay for binomial water suppression
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; d19 = (1/(2*d)), d = distance of next null (in Hz)
;L3: loop for phase sensitive 2D using States-TPPI method: l3 = td1/2
;in0: 1/(1 * SW) = 2 * DW
;nd0: 1
;NS: 8 * n
;DS: 16
;td1: number of experiments
;MC2: States-TPPI
;use gradient program (GRDPROG) : 4sine
;use gradient ratio: cnst21 : cnst22 : cnst23 : cnst24 
; 40 : 40 : 7 : 7
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Pulse program
The program running the pulse sequense.
Pulse programs are outlined in Appendix B.
ns
Number of scans in the experiment.
p1
Duration of the pulse
o1p
Defines the midle of the spectrum, usually situated at the water signal.
rg
Resiever gain, a multiplication of the signal from the resiever coil before entering the digital
converter.
d1
Waiting time between the aquisition and the next pulse.
td
Time domain, number of datapoints from the FID sampled
sw
Spectral width in ppm
pl18
Radio frequency pulse power attenuation for the gradient pulses in the w5 water suppression
sequense
p0
Pulse duration for the gradients in the w5 water suppression sequense
p28
Pulse duration for the gradients in the w5 water suppression sequense
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d19
Delay for binominal water suppression
te
Temperature kept by the temperature control unit
ds
Number of dummy scans in the experiment
aq
Aquisition time, set automatically from td and swh
dw
Dwell time, the intervals between the points making up the FID.
de
Pre-scan delay
p19
Delay for the binominal water suppression in the 3-9-19 pulse sequense
d8
Mixing time
si
Spectral size
WDW
Window function, “qsine” means a squared sine bell function
SSB
Fase of the window function, “2” turnes WDW to a cosine function
lb
Line broadening
ME_Mod
Linear prediction can be turned on using LPfc
LPBIN
Number of data points in predicted FIDs
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MC2
Detection scheme
d16
Delay. Used to calculate big delta in a spin-echo pulse-sequense
p16
Little delta in both spin-echo and stimulated spin-echo pulse-sequences
Also used to calculate big delta in a spin-echo pulse-sequence
d20
Big delta in a stimulated spin-echo pulse-sequence
d21
Delay
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